: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

As of October 2023, Amedeo had
12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription

Articles published in Inflamm Bowel Dis
Retrieve available abstracts of 972 articles:
HTML format

Single Articles

November 2023

DISTANTE M, Rotulo S, Ranalli M, Pedace E, et al
Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 23:izad275. doi: 10.1093.
PubMed Abstract available

ROSHANOV PS, Khanna R
The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Nov 21:izad281. doi: 10.1093.
PubMed

SHAW VR, Byun J, Pettit RW, Hou JK, et al
An Atlas Characterizing the Shared Genetic Architecture of Inflammatory Bowel Disease with Clinical and Behavioral Traits.
Inflamm Bowel Dis. 2023 Nov 20:izad269. doi: 10.1093.
PubMed Abstract available

FERNANDES SR, Bernardo S, Saraiva S, Rita Goncalves A, et al
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched Analysis.
Inflamm Bowel Dis. 2023 Nov 20:izad272. doi: 10.1093.
PubMed Abstract available

SIGALL BONEH R, Westoby C, Oseran I, Sarbagili-Shabat C, et al
The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.
Inflamm Bowel Dis. 2023 Nov 18:izad255. doi: 10.1093.
PubMed Abstract available

FIELD J, Fenton C, Zhang L, Brickman C, et al
Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men.
Inflamm Bowel Dis. 2023 Nov 10:izad266. doi: 10.1093.
PubMed Abstract available

WONG SY, Colombel JF
Cancer Screening in Patients With Inflammatory Bowel Disease: Don't Forget the Anus!
Inflamm Bowel Dis. 2023 Nov 10:izad267. doi: 10.1093.
PubMed

YAMADA S, Honzawa Y, Yamamoto S, Matsuura M, et al
Single Nucleotide Polymorphisms of the MEFV Gene E148Q Are Highly Associated With Disease Phenotype in Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 10:izad259. doi: 10.1093.
PubMed Abstract available

LITTLE RD, Swaine A, Reynolds R, Gibson DJ, et al
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Inflamm Bowel Dis. 2023 Nov 10:izad248. doi: 10.1093.
PubMed Abstract available

CHEW DCH, Khoo XH, Lee TS, Chin KY, et al
A Systematic Review on the Increasing Incidence of Inflammatory Bowel Disease in Southeast Asia: Looking Beyond the Urbanization Phenomenon.
Inflamm Bowel Dis. 2023 Nov 3:izad189. doi: 10.1093.
PubMed Abstract available

GONZALEZ CUETO E, Edmans M, Wellens J, Cadwell K, et al
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Nov 3:izad265. doi: 10.1093.
PubMed

TUBAU-JUNI N, Hontecillas R, Leber AJ, Alva SS, et al
Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 2:izad258. doi: 10.1093.
PubMed Abstract available

RUBIN DT, Torres J, Dotan I, Xu LT, et al
An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts.
Inflamm Bowel Dis. 2023 Nov 2:izad247. doi: 10.1093.
PubMed Abstract available

FEATHERS A, Lovasi GS, Grigoryan Z, Beem K, et al
Crohn's Disease Mortality and Ambient Air Pollution in New York City.
Inflamm Bowel Dis. 2023 Nov 2:izad243. doi: 10.1093.
PubMed Abstract available

CHANG S, Hong S, Hudesman D, Remzi F, et al
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2023;29:1769-1777.
PubMed Abstract available

LUO Y, Schmidt N, Dubinsky MC, Jaffin B, et al
Evaluating lleal Pouch Anal Anastomosis Function: Time to Expand Our ARM-amentarium.
Inflamm Bowel Dis. 2023;29:1819-1825.
PubMed Abstract available

NARDONE OM, Calabrese G, Barberio B, Giglio MC, et al
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis.
Inflamm Bowel Dis. 2023 Nov 1:izad252. doi: 10.1093.
PubMed Abstract available

October 2023

KRUGLIAK CLEVELAND N, Ghosh S, Chastek B, Bancroft T, et al
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
Inflamm Bowel Dis. 2023 Oct 31:izad245. doi: 10.1093.
PubMed Abstract available

GUO A, Ostensson M, Stordal K, Ludvigsson J, et al
Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
Inflamm Bowel Dis. 2023 Oct 31:izad257. doi: 10.1093.
PubMed Abstract available

RIGGOTT C, Fairbrass KM, Selinger CP, Gracie DJ, et al
Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study.
Inflamm Bowel Dis. 2023 Oct 31:izad256. doi: 10.1093.
PubMed Abstract available

Correction to: Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
Inflamm Bowel Dis. 2023 Oct 27:izad261. doi: 10.1093.
PubMed

FU J, Chai C, Chen L, Cai M, et al
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Oct 27:izad262. doi: 10.1093.
PubMed Abstract available

HUANG Z, Cheng W, Chao K, Tang J, et al
Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Oct 27:izad251. doi: 10.1093.
PubMed Abstract available

ASSADSANGABI A, Evans CA, Corfe BM, Lobo AJ, et al
Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach.
Inflamm Bowel Dis. 2023 Oct 27:izad241. doi: 10.1093.
PubMed Abstract available

WELLENS J, Chen J, Fu T, Zhang Y, et al
Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
Inflamm Bowel Dis. 2023 Oct 25:izad249. doi: 10.1093.
PubMed

SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
Inflamm Bowel Dis. 2023 Oct 25:izad246. doi: 10.1093.
PubMed Abstract available

Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Inflamm Bowel Dis. 2023 Oct 25:izad260. doi: 10.1093.
PubMed

LUND K, Zegers FD, Nielsen J, Brodersen JB, et al
Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study.
Inflamm Bowel Dis. 2023 Oct 24:izad244. doi: 10.1093.
PubMed Abstract available

DIMOPOULOS-VERMA A, Hong S, Axelrad JE
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.
Inflamm Bowel Dis. 2023 Oct 20:izad253. doi: 10.1093.
PubMed Abstract available

DONNELLY M, Driever D, Ryan EJ, Elliott JA, et al
Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
Inflamm Bowel Dis. 2023 Oct 20:izad225. doi: 10.1093.
PubMed Abstract available

DAL BUONO A, Armuzzi A
Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Oct 20:izad254. doi: 10.1093.
PubMed

MASSIRONI S, Sileri P, Danese S
Get Fit: Muscle Health for Crohn's Disease Surgical Outcome Optimization.
Inflamm Bowel Dis. 2023 Oct 20:izad235. doi: 10.1093.
PubMed

PRAKASH P, Dua A, Blumenfeld Y, Chen PH, et al
Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis.
Inflamm Bowel Dis. 2023 Oct 19:izad250. doi: 10.1093.
PubMed Abstract available

COLLEN LV, Mitsialis V, Kim DY, Bresnahan M, et al
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 17:izad196. doi: 10.1093.
PubMed Abstract available

KRUGLIAK CLEVELAND N, Miyatani Y, Picker EA, Rubin DT, et al
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Oct 16:izad237. doi: 10.1093.
PubMed

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
Inflamm Bowel Dis. 2023 Oct 16:izad242. doi: 10.1093.
PubMed Abstract available

SCHMOYER CJ, Sun K, Zack J, Kumar P, et al
Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions.
Inflamm Bowel Dis. 2023 Oct 11:izad226. doi: 10.1093.
PubMed Abstract available

TARIQ R, Loftus EV
Home-based Biologic Infusions for Inflammatory Bowel Disease: Are We Ready for Prime Time?
Inflamm Bowel Dis. 2023 Oct 11:izad240. doi: 10.1093.
PubMed

SMITH RA, Desai A, Hashash JG, Hayney MS, et al
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.
Inflamm Bowel Dis. 2023 Oct 10:izad233. doi: 10.1093.
PubMed

MARTINELLI M, Romeo E, Caldaro T, Dimakou K, et al
De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN.
Inflamm Bowel Dis. 2023 Oct 10:izad199. doi: 10.1093.
PubMed Abstract available

O'SHEA D, Picoraro JA
De Novo Crohn's Disease in the Pediatric Pouch.
Inflamm Bowel Dis. 2023 Oct 10:izad231. doi: 10.1093.
PubMed Abstract available

KLEEBAYOON A, Wiwanitkit V
SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 10:izad230. doi: 10.1093.
PubMed

Correction to: Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
Inflamm Bowel Dis. 2023 Oct 9:izad239. doi: 10.1093.
PubMed

REIJNTJES M, de Jong D, Wessels E, Goetgebuer R, et al
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential Overdiagnoses.
Inflamm Bowel Dis. 2023 Oct 6:izad228. doi: 10.1093.
PubMed Abstract available

RAO V, Cockburn E, Segal JP
Is Ulcerative Colitis Really Ever "Cleared?".
Inflamm Bowel Dis. 2023 Oct 5:izad234. doi: 10.1093.
PubMed

LAHEIJ RLH, van Knippenberg YMW, Heil ALJ, Mannaerts BJW, et al
The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clini
Inflamm Bowel Dis. 2023 Oct 4:izad216. doi: 10.1093.
PubMed Abstract available

BISLENGHI G, Van Den Bossch J, Fieuws S, Wolthuis A, et al
Appearance of the Bowel and Mesentery During Surgery Is Not Predictive of Postoperative Recurrence After Ileocecal Resection for Crohn's Disease: A Prospective Monocentric Study.
Inflamm Bowel Dis. 2023 Oct 4:izad227. doi: 10.1093.
PubMed Abstract available

YANG W, Cong Y
Exploring Colitis through Dynamic T Cell Adoptive Transfer Models.
Inflamm Bowel Dis. 2023;29:1673-1680.
PubMed Abstract available

YIN Y, Wan J, Yu J, Wu K, et al
Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
Inflamm Bowel Dis. 2023;29:1648-1657.
PubMed Abstract available

WEIDINGER C, Siegmund B
Deciphering Cellular Networks in Creeping Fat.
Inflamm Bowel Dis. 2023;29:1670-1672.
PubMed

September 2023

TYRODE G, Lakkis Z, Vernerey D, Falcoz A, et al
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease.
Inflamm Bowel Dis. 2023 Sep 30:izad214. doi: 10.1093.
PubMed Abstract available

LEE YJ, Li D, Mujukian A, Debbas P, et al
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 29:izad198. doi: 10.1093.
PubMed

CATASSI G, D'Arcangelo G, Norsa L, Bramuzzo M, et al
Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
Inflamm Bowel Dis. 2023 Sep 28:izad218. doi: 10.1093.
PubMed Abstract available

METWALY A, Haller D
The TNF?ARE Model of Crohn's Disease-like Ileitis.
Inflamm Bowel Dis. 2023 Sep 26:izad205. doi: 10.1093.
PubMed Abstract available

LIU GXH, Day AS
Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
Inflamm Bowel Dis. 2023 Sep 25:izad213. doi: 10.1093.
PubMed Abstract available

PATEL R, Marrie RA, Bernstein CN, Bolton JM, et al
Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study.
Inflamm Bowel Dis. 2023 Sep 22:izad204. doi: 10.1093.
PubMed Abstract available

SIGVARDSSON I, Stordal K, Ostensson M, Guo A, et al
Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
Inflamm Bowel Dis. 2023 Sep 22:izad220. doi: 10.1093.
PubMed Abstract available

GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?".
Inflamm Bowel Dis. 2023 Sep 21:izad222. doi: 10.1093.
PubMed

ERRIDGE S, Sodergren MH
Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Inflamm Bowel Dis. 2023 Sep 21:izad221. doi: 10.1093.
PubMed

BARBER GE, Zhuo J, Okafor PN, Streett S, et al
Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 21:izad207. doi: 10.1093.
PubMed Abstract available

SNINSKY JA, Staicu AM, Barnes EL
In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk.
Inflamm Bowel Dis. 2023 Sep 21:izad215. doi: 10.1093.
PubMed

LASA J, Nazario E, De Sanctis G, Fernandez Recalde M, et al
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study.
Inflamm Bowel Dis. 2023 Sep 21:izad217. doi: 10.1093.
PubMed Abstract available

LI WAI SUEN CFD, Seah D, Choy MC, De Cruz P, et al
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 19:izad183. doi: 10.1093.
PubMed Abstract available

NASEEM K, Sohail A, Quang Nguyen V, Khan A, et al
Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
Inflamm Bowel Dis. 2023 Sep 19:izad200. doi: 10.1093.
PubMed Abstract available

SHAH S, Shillington AC, Kabagambe EK, Deering KL, et al
Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey.
Inflamm Bowel Dis. 2023 Sep 13:izad194. doi: 10.1093.
PubMed Abstract available

GUGLIELMI G, Crucitta S, Bertani L, Ruglioni M, et al
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-alpha Biologics.
Inflamm Bowel Dis. 2023 Sep 11:izad181. doi: 10.1093.
PubMed Abstract available

DEL CHIERICO F, Cardile S, Baldelli V, Alterio T, et al
Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 11:izad203. doi: 10.1093.
PubMed Abstract available

Correction to: Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 9:izad223. doi: 10.1093.
PubMed

MIYATANI Y, Micic D
Revisiting the Risk of Hospital Readmission in Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 8:izad212. doi: 10.1093.
PubMed

KIM SH, Buhle A, Roberts A, Singh N, et al
Multidisciplinary Inflammatory Bowel Disease Conference: The Impact of the Expert Pathologist on Patient Care.
Inflamm Bowel Dis. 2023 Sep 6:izad192. doi: 10.1093.
PubMed Abstract available

SITKIN S, Pokrotnieks J
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 6:izad209. doi: 10.1093.
PubMed

DI MARTINO L
Reply: "Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-Modulating Therapy for Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2023 Sep 6:izad206. doi: 10.1093.
PubMed

SINGH A, Midha V, Kochhar GS, Shen B, et al
Management of Perianal Fistulizing Crohn's Disease.
Inflamm Bowel Dis. 2023 Sep 6:izad195. doi: 10.1093.
PubMed Abstract available

CROUWEL F, Bayoumy AB, Mulder CJJ, Peters JHC, et al
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Sep 2:izad197. doi: 10.1093.
PubMed Abstract available

HERRERA-DEGUISE C, Varela E, Sarrabayrouse G, Pozuelo Del Rio M, et al
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
Inflamm Bowel Dis. 2023;29:1362-1369.
PubMed Abstract available

RUTHERFORD D, Ho GT
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:1488-1498.
PubMed Abstract available

NORGARD BM, Zegers FD, Nielsen J, Knudsen T, et al
COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
Inflamm Bowel Dis. 2023;29:1470-1476.
PubMed Abstract available

AKIYAMA S, Cohen NA, Kayal M, Dubinsky MC, et al
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.
Inflamm Bowel Dis. 2023;29:1504-1507.
PubMed

AINSWORTH MA
How to Minimize Placebo Response and Remission Rates.
Inflamm Bowel Dis. 2023;29:1508-1509.
PubMed

IACUCCI M, Jeffery L, Acharjee A, Grisan E, et al
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
Inflamm Bowel Dis. 2023;29:1409-1420.
PubMed Abstract available

OUTTIER A, Gijbels L, Noman M, Verstockt B, et al
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes.
Inflamm Bowel Dis. 2023;29:1440-1445.
PubMed Abstract available

MASSIRONI S, Pirola L, Mulinacci G, Ciaccio A, et al
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
Inflamm Bowel Dis. 2023;29:1477-1487.
PubMed Abstract available

CUOMO M, Carobbio A, Aloi M, Alvisi P, et al
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
Inflamm Bowel Dis. 2023;29:1380-1389.
PubMed Abstract available

August 2023

LIU T, Lin CH, Chen YL, Yeh CC, et al
Relationship Between Rectal Swab and Tissue Samples in Mucosa-associated Microbiota in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 31:izad179. doi: 10.1093.
PubMed Abstract available

BHAT S, Lyu R, Agarwal M, Becker M, et al
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
Inflamm Bowel Dis. 2023 Aug 31:izad143. doi: 10.1093.
PubMed Abstract available

JACOBS JP, Sauk JS, Ahdoot AI, Liang F, et al
Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk.
Inflamm Bowel Dis. 2023 Aug 31:izad185. doi: 10.1093.
PubMed Abstract available

YU N, Wu K, Samyue T, Fry S, et al
Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service.
Inflamm Bowel Dis. 2023 Aug 29:izad145. doi: 10.1093.
PubMed Abstract available

TOKUSHIMA K, Jimbo K, Suzuki M, Endo Y, et al
Differentiation of Active Ulcerative Colitis vs Noninflammatory Bowel Disease Proctitis by Transperineal Superb Microvascular Imaging.
Inflamm Bowel Dis. 2023 Aug 29:izad186. doi: 10.1093.
PubMed Abstract available

REN H, Kang J, Wang J, Su J, et al
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.
Inflamm Bowel Dis. 2023 Aug 24:izad184. doi: 10.1093.
PubMed Abstract available

MOULTON CD, Jordan C, Hayee B, Chalder T, et al
All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Aug 24:izad193. doi: 10.1093.
PubMed

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States.
Inflamm Bowel Dis. 2023 Aug 24:izad165. doi: 10.1093.
PubMed

WANDS DIF, Gianolio L, Wilson DC, Hansen R, et al
Nationwide Real-World Exclusive Enteral Nutrition Practice Over Time: Persistence of Use as Induction for Pediatric Crohn's Disease and Emerging Combination Strategy With Biologics.
Inflamm Bowel Dis. 2023 Aug 24:izad167. doi: 10.1093.
PubMed Abstract available

LONG MD, Parlett L, Lewis JD, Haynes K, et al
Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 23:izad176. doi: 10.1093.
PubMed Abstract available

ZINGER CH, Ringel Y, Eitan M, Openhaim M, et al
Upadacitinib for Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Aug 23:izad180. doi: 10.1093.
PubMed

BROWNSON E, Saunders J, Jatkowska A, White B, et al
Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy.
Inflamm Bowel Dis. 2023 Aug 23:izad174. doi: 10.1093.
PubMed Abstract available

MARTINEZ-DOMINGUEZ SJ, Garcia-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, et al
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Inflamm Bowel Dis. 2023 Aug 22:izad175. doi: 10.1093.
PubMed Abstract available

TRACY MS, Challa PK, Lopes EW, Khalili H, et al
Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program.
Inflamm Bowel Dis. 2023 Aug 21:izad170. doi: 10.1093.
PubMed

COONEY R, Tang D, Barrett K, Russell RK, et al
Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study.
Inflamm Bowel Dis. 2023 Aug 21:izad169. doi: 10.1093.
PubMed Abstract available

TRAVIS S, Potts Bleakman A, Dubinsky MC, Schreiber S, et al
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Aug 21:izad142. doi: 10.1093.
PubMed Abstract available

D'ARCANGELO G, Russo G, Aloi M, Ruggiero C, et al
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.
Inflamm Bowel Dis. 2023 Aug 21:izad173. doi: 10.1093.
PubMed Abstract available

RASMUSSEN J, Norgard BM, Nielsen RG, Boggild H, et al
Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study.
Inflamm Bowel Dis. 2023 Aug 21:izad157. doi: 10.1093.
PubMed Abstract available

OSHIMA N, Hiraoka S, Hayashi R, Takahashi S, et al
Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Aug 19:izad150. doi: 10.1093.
PubMed Abstract available

HANZEL J, Ma C, De Silva TA, Alphonsus L, et al
Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration.
Inflamm Bowel Dis. 2023 Aug 17:izad168. doi: 10.1093.
PubMed

GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
Inflamm Bowel Dis. 2023 Aug 14:izad151. doi: 10.1093.
PubMed Abstract available

ZHU Z, Jia Y, Li FR, Li Y, et al
Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes.
Inflamm Bowel Dis. 2023 Aug 14:izad163. doi: 10.1093.
PubMed Abstract available

MUJUKIAN A, Kumar R, Li D, Debbas P, et al
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
Inflamm Bowel Dis. 2023 Aug 9:izad114. doi: 10.1093.
PubMed Abstract available

D'AMICO F, Magro F, Siegmund B, Kobayashi T, et al
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus.
Inflamm Bowel Dis. 2023 Aug 7:izad159. doi: 10.1093.
PubMed Abstract available

RESAL T, Bacsur P, Keresztes C, Balint A, et al
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
Inflamm Bowel Dis. 2023 Aug 5:izad135. doi: 10.1093.
PubMed Abstract available

DUBOIS KE, Blake CE, Rudisill C, Harrison SE, et al
Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort.
Inflamm Bowel Dis. 2023 Aug 5:izad139. doi: 10.1093.
PubMed Abstract available

DI PETRILLO A, Kumar A, Onali S, Favale A, et al
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 5:izad161. doi: 10.1093.
PubMed Abstract available

SHEHAB M, Al Akram S, Hassan A, Alrashed F, et al
Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Aug 4:izad119. doi: 10.1093.
PubMed Abstract available

DESAI A, Soni A, Hayney MS, Hashash JG, et al
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study.
Inflamm Bowel Dis. 2023 Aug 4:izad162. doi: 10.1093.
PubMed Abstract available

WANG Q, Chen F, Peng Y, Yi X, et al
Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 4:izad153. doi: 10.1093.
PubMed Abstract available

VIGANO C, Palermo A, Mulinacci G, Pirola L, et al
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).
Inflamm Bowel Dis. 2023 Aug 3:izad146. doi: 10.1093.
PubMed Abstract available

ALDARS-GARCIA L, Gil-Redondo R, Embade N, Riestra S, et al
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naive Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Aug 3:izad154. doi: 10.1093.
PubMed Abstract available

ZHU N, Zhu J, Mei Q
Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD.
Inflamm Bowel Dis. 2023;29:e31.
PubMed

XIE K, Ortiz Cerda T, Schroder A, Shiung N, et al
Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD.
Inflamm Bowel Dis. 2023;29:e32.
PubMed

BAMIAS G, Kitsou K, Rivera-Nieves J
The Underappreciated Role of Secretory IgA in IBD.
Inflamm Bowel Dis. 2023;29:1327-1341.
PubMed Abstract available

ROSEIRA J, Santiago M, Estevinho MM, Moreira P, et al
Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.
Inflamm Bowel Dis. 2023;29:1231-1243.
PubMed Abstract available

KAMP KJ, Hawes SE, Tse CS, Singh S, et al
Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment.
Inflamm Bowel Dis. 2023;29:1255-1262.
PubMed Abstract available

PRAY C, Wong ECL, Aruljothy A, Dulai PS, et al
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.
Inflamm Bowel Dis. 2023;29:1263-1271.
PubMed Abstract available

July 2023

CROWLEY E, Ma C, Guizzetti L, Zou G, et al
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
Inflamm Bowel Dis. 2023 Jul 31:izad134. doi: 10.1093.
PubMed Abstract available

MARK-CHRISTENSEN A, Kristiansen EB, Myrelid P, Laurberg S, et al
Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
Inflamm Bowel Dis. 2023 Jul 31:izad141. doi: 10.1093.
PubMed Abstract available

OTTEN AT, Dijkstra G, Visschedijk MC, Bourgonje AR, et al
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients.
Inflamm Bowel Dis. 2023 Jul 31:izad144. doi: 10.1093.
PubMed

DALAL RS, Lund K, Zegers FD, Friedman S, et al
Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
Inflamm Bowel Dis. 2023 Jul 31:izad156. doi: 10.1093.
PubMed Abstract available

BOKEMEYER B, Plachta-Danielzik S, di Giuseppe R, Efken P, et al
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naive Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Inflamm Bowel Dis. 2023 Jul 31:izad138. doi: 10.1093.
PubMed Abstract available

LAW CCY, Tkachuk B, Lieto S, Narula N, et al
Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Jul 28:izad149. doi: 10.1093.
PubMed Abstract available

OKITA M, Nakashima K, Yamamura T, Matsui S, et al
Systematic Review and Meta-Analysis of the Use of Serum Leucine-Rich Alpha-2 Glycoprotein to Assess Crohn's Disease Activity.
Inflamm Bowel Dis. 2023 Jul 28:izad128. doi: 10.1093.
PubMed Abstract available

LEE S, Seow CH, Nerenberg K, Bertazzon S, et al
Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
Inflamm Bowel Dis. 2023 Jul 27:izad147. doi: 10.1093.
PubMed Abstract available

DALAL RS, Kallumkal G, Cabral HJ, Bachour S, et al
Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Jul 27:izad155. doi: 10.1093.
PubMed

MCNAMARA J, Connor SJ, Andrews JM
The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform.
Inflamm Bowel Dis. 2023 Jul 25:izad148. doi: 10.1093.
PubMed

MARAFINI I, De Cristofaro E, Salvatori S, Calabrese E, et al
Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study.
Inflamm Bowel Dis. 2023 Jul 21:izad125. doi: 10.1093.
PubMed Abstract available

ALIZADEH M, Ali O, Cross RK
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 21:izad131. doi: 10.1093.
PubMed Abstract available

ROMANO D, Chesterman S, Fuller-Tyszkiewicz M, Evans S, et al
Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress.
Inflamm Bowel Dis. 2023 Jul 21:izad122. doi: 10.1093.
PubMed Abstract available

PASCUAL-OLIVER A, Casas-Deza D, Cuaran C, Garcia-Lopez S, et al
HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Jul 18:izad130. doi: 10.1093.
PubMed Abstract available

LIU F, Xu W, Wang Y, Huang Z, et al
LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jul 15:izad140. doi: 10.1093.
PubMed Abstract available

MCHENRY S, Glover M, Ahmed A, Alayo Q, et al
NAFLD Is Associated With Quiescent Rather Than Active Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 15:izad129. doi: 10.1093.
PubMed Abstract available

BHAT S, Click B, Regueiro M
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
Inflamm Bowel Dis. 2023 Jul 14:izad120. doi: 10.1093.
PubMed Abstract available

ROOSENBOOM B, Wahab PJ, Smids C, Meijer J, et al
Mucosal alpha4beta7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Jul 12:izad123. doi: 10.1093.
PubMed Abstract available

KOGAN L, Townsend MJ, Raj D, Levy AN, et al
Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Jul 8:izad121. doi: 10.1093.
PubMed

ZENG Z, Cheng S, Li X, Liu H, et al
Glycolytic Activation of CD14+ Intestinal Macrophages Contributes to the Inflammatory Responses via Exosomal Membrane Tumor Necrosis Factor in Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 5:izad117. doi: 10.1093.
PubMed Abstract available

DAI C, Huang YH
Frail Phenotype in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023;29:e30.
PubMed

RAUSCH P, Ellul S, Pisani A, Bang C, et al
Microbial Dynamics in Newly Diagnosed and Treatment Naive IBD Patients in the Mediterranean.
Inflamm Bowel Dis. 2023;29:1118-1132.
PubMed Abstract available

GARCIA-HERNANDEZ V, Raya-Sandino A, Azcutia V, Miranda J, et al
Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair.
Inflamm Bowel Dis. 2023;29:1133-1144.
PubMed Abstract available

LAM GA, Albarrak H, McColl CJ, Pizarro A, et al
The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders.
Inflamm Bowel Dis. 2023;29:1153-1164.
PubMed Abstract available

ADLER J, Colletti RB, Noonan L, Berzin TM, et al
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity.
Inflamm Bowel Dis. 2023;29:1089-1097.
PubMed Abstract available

SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
Young Adult Male Patients With Childhood-onset IBD Have Increased Risks of Compromised Cortical and Trabecular Bone Microstructures.
Inflamm Bowel Dis. 2023;29:1065-1072.
PubMed Abstract available

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naive Crohn's Disease.
Inflamm Bowel Dis. 2023;29:1015-1023.
PubMed Abstract available

PROIETTI E, Pauwels RWM, van der Woude CJ, Doukas M, et al
Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction.
Inflamm Bowel Dis. 2023;29:1038-1046.
PubMed Abstract available

CHANDAN S, Dhindsa BS, Khan SR, Deliwala S, et al
Endoscopic Stenting in Crohn's Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes.
Inflamm Bowel Dis. 2023;29:1145-1152.
PubMed Abstract available

June 2023

MACALUSO FS, Principi M, Facciotti F, Contaldo A, et al
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.
Inflamm Bowel Dis. 2023 Jun 30:izad118. doi: 10.1093.
PubMed

ADIMADHYAM S, Lewis JD, Simon AL, Wolfe AE, et al
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Jun 26:izad115. doi: 10.1093.
PubMed Abstract available

WONG SY, Wellens J, Helmus D, Marlow L, et al
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
Inflamm Bowel Dis. 2023 Jun 24:izad097. doi: 10.1093.
PubMed Abstract available

ITO N, Kudo T, Eguchi H, Jimbo K, et al
Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 16:izad116. doi: 10.1093.
PubMed Abstract available

TE GROEN M, Derikx LAAP, van Lierop L, Ylstra B, et al
Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.
Inflamm Bowel Dis. 2023 Jun 16:izad112. doi: 10.1093.
PubMed

MULES TC, Lavender B, Maclean K, Vacca F, et al
Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial.
Inflamm Bowel Dis. 2023 Jun 15:izad110. doi: 10.1093.
PubMed Abstract available

SEHGAL P, Su S, Zech J, Nobel Y, et al
Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Inflamm Bowel Dis. 2023 Jun 12:izad111. doi: 10.1093.
PubMed Abstract available

TANEJA V, Anand RS, El-Dallal M, Dong J, et al
Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Jun 10:izad108. doi: 10.1093.
PubMed Abstract available

ODUFALU FD, Dubinsky MC, Peyrin-Biroulet L, Ylanne K, et al
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
Inflamm Bowel Dis. 2023 Jun 10:izad102. doi: 10.1093.
PubMed Abstract available

RHUDY CN, Perry CL, Hawk GS, Flomenhoft DR, et al
Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.
Inflamm Bowel Dis. 2023 Jun 6:izad096. doi: 10.1093.
PubMed Abstract available

SCALDAFERRI F, D'Onofrio AM, Calia R, Di Vincenzo F, et al
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center.
Inflamm Bowel Dis. 2023 Jun 6:izad091. doi: 10.1093.
PubMed Abstract available

SUTTICHAIMONGKOL T, Loftus EV
Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Jun 6:izad104. doi: 10.1093.
PubMed Abstract available

SARTER H, Savoye G, Marot G, Ley D, et al
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.
Inflamm Bowel Dis. 2023 Jun 2:izad090. doi: 10.1093.
PubMed Abstract available

OTTEN AT, van der Meulen HH, Steenhuis M, Loeff FC, et al
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 2:izad103. doi: 10.1093.
PubMed Abstract available

LIGHTNER AL, Otero-Pineiro A, Reese J, Ream J, et al
A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Inflamm Bowel Dis. 2023 Jun 1:izad100. doi: 10.1093.
PubMed Abstract available

CARPINETI C, Mugheddu C, Cadoni M, Anedda J, et al
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab.
Inflamm Bowel Dis. 2023 Jun 1:izad107. doi: 10.1093.
PubMed

KHROM M, Li D, Naito T, Lee HS, et al
Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 1:izad089. doi: 10.1093.
PubMed Abstract available

EL HAJJ W, Buisson A, Olympie A, Ravel MH, et al
Impact of Inflammatory Bowel Disease on Patients' Caregivers: Results From a French Survey.
Inflamm Bowel Dis. 2023 Jun 1:izad093. doi: 10.1093.
PubMed Abstract available

TSOUNIS EP, Aggeletopoulou I, Mouzaki A, Triantos C, et al
Creeping Fat in the Pathogenesis of Crohn's Disease: An Orchestrator or a Silent Bystander?
Inflamm Bowel Dis. 2023 Jun 1:izad095. doi: 10.1093.
PubMed Abstract available

HONG SN, Song JH, Kim SJ, Park YH, et al
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Jun 1:izad094. doi: 10.1093.
PubMed Abstract available

KARIME C, Farraye FA, Hashash JG
Use of Immune Checkpoint Inhibitors in Patients With Inflammatory Bowel Disease After Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2023 Jun 1:izad098. doi: 10.1093.
PubMed

CUSHING KC, Chen Y, Du X, Chen V, et al
Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases.
Inflamm Bowel Dis. 2023;29:938-945.
PubMed Abstract available

SOUSA P, Noor NM
Revisiting Drug Development for Older Molecules in IBD.
Inflamm Bowel Dis. 2023;29:1012-1013.
PubMed

BOUHNIK Y, Atreya R, Casey D, Gorecki M, et al
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment.
Inflamm Bowel Dis. 2023;29:898-913.
PubMed Abstract available

RIVIERE P, Kanters C, Pellet G, Ni A, et al
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
Inflamm Bowel Dis. 2023;29:923-931.
PubMed Abstract available

SHORE BM, Weaver KN, Allegretti JR, Herfarth HH, et al
Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn's-like Disease of the Pouch.
Inflamm Bowel Dis. 2023;29:932-937.
PubMed Abstract available

AXELRAD JE, Li T, Bachour SP, Nakamura TI, et al
Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Inflamm Bowel Dis. 2023;29:888-897.
PubMed Abstract available

FAN Y, Zhang L, Omidakhsh N, Bohn RL, et al
Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Inflamm Bowel Dis. 2023;29:914-922.
PubMed Abstract available

WONG ECL, Yusuf A, Pokryszka J, Dulai PS, et al
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.
Inflamm Bowel Dis. 2023;29:875-882.
PubMed Abstract available

SEDANO R, Guizzetti L, McDonald C, Beaton M, et al
Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naive Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center.
Inflamm Bowel Dis. 2023;29:866-874.
PubMed Abstract available

May 2023

HSU P, Choi EJ, Patel SA, Wong WH, et al
Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
Inflamm Bowel Dis. 2023 May 26:izad084. doi: 10.1093.
PubMed Abstract available

CHAVANNES M, Hart L, Hayati Rezvan P, Dillman JR, et al
Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study.
Inflamm Bowel Dis. 2023 May 25:izad083. doi: 10.1093.
PubMed Abstract available

HSIA K, Zhao N, Chung M, Algarrahi K, et al
Alterations in the Fungal Microbiome in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 May 23:izad082. doi: 10.1093.
PubMed Abstract available

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
Inflamm Bowel Dis. 2023 May 20:izad087. doi: 10.1093.
PubMed Abstract available

LOEB L, Nasir A, Picco MF, Hashash JG, et al
Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 May 17:izad088. doi: 10.1093.
PubMed

MA R, Zhu Y, Li X, Hu S, et al
A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.
Inflamm Bowel Dis. 2023 May 17:izad080. doi: 10.1093.
PubMed Abstract available

KOPYLOV U, Burisch J, Ben-Horin S, Braegger F, et al
Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study.
Inflamm Bowel Dis. 2023 May 9:izad075. doi: 10.1093.
PubMed Abstract available

MCDONALD C, Kerr H, Gibbons E, Lukose T, et al
Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn's Disease: An Experience of 2 IBD Centers.
Inflamm Bowel Dis. 2023 May 9:izad073. doi: 10.1093.
PubMed Abstract available

CHEN X, Elson CO, Dunkin D
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.
Inflamm Bowel Dis. 2023;29:798-807.
PubMed Abstract available

LAI HJ, Doan HT, Lin EY, Chiu YL, et al
Histones of Neutrophil Extracellular Traps Directly Disrupt the Permeability and Integrity of the Intestinal Epithelial Barrier.
Inflamm Bowel Dis. 2023;29:783-797.
PubMed Abstract available

CAO H, Diao J, Liu H, Liu S, et al
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:818-829.
PubMed Abstract available

BEZZIO C, Fiorino G, Ribaldone DG, Armuzzi A, et al
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame.
Inflamm Bowel Dis. 2023;29:834-836.
PubMed

DALAL RS, Pruce JC, Allegretti JR
Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:830-833.
PubMed

HUTFLESS S, Jasper RA, Tilak A, Ghosh T, et al
A Systematic Review of Crohn's Disease Case Definitions in Administrative or Claims Databases.
Inflamm Bowel Dis. 2023;29:705-715.
PubMed Abstract available

CHAN M, Fung M, Chin Koon Siw K, Khanna R, et al
Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Inflamm Bowel Dis. 2023;29:763-770.
PubMed Abstract available

HOLKO P, Kawalec P, Sajak-Szczerba M, Avedano L, et al
Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.
Inflamm Bowel Dis. 2023;29:752-762.
PubMed Abstract available

NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
Inflamm Bowel Dis. 2023;29:716-725.
PubMed Abstract available

April 2023

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.
Inflamm Bowel Dis. 2023 Apr 28:izad074. doi: 10.1093.
PubMed Abstract available

ZITTAN E, Mahajna H, Salomon N
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts.
Inflamm Bowel Dis. 2023 Apr 28:izad072. doi: 10.1093.
PubMed

GKIKAS K, Wan M, Svolos V, Nichols B, et al
YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 26:izad076. doi: 10.1093.
PubMed Abstract available

ATIA O, Magen Rimon R, Ledderman N, Greenfeld S, et al
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
Inflamm Bowel Dis. 2023 Apr 21:izad057. doi: 10.1093.
PubMed Abstract available

YANG X, Shi J, Wang G, Chen H, et al
Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Apr 20:izad060. doi: 10.1093.
PubMed Abstract available

MCBRIDE RB, Suarez-Farinas M, Ko HM, Chen X, et al
Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Apr 19:izad063. doi: 10.1093.
PubMed Abstract available

YANG Y, Carrero JJ
Reply: Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
Inflamm Bowel Dis. 2023 Apr 19:izad069. doi: 10.1093.
PubMed

LIU M, Ye Z, Sun Z
Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
Inflamm Bowel Dis. 2023 Apr 19:izad067. doi: 10.1093.
PubMed

SCHELL TL, Ramirez O, Almasry M, Farraye FA, et al
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad068. doi: 10.1093.
PubMed

VASUDEVAN A, Tharayil V, Raffals LH, Bruining DH, et al
Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad065. doi: 10.1093.
PubMed Abstract available

NOURELDIN M, Newman KL, Higgins PDR, Piette JD, et al
Profiles of Web-based Portal Users with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad056. doi: 10.1093.
PubMed Abstract available

DAWWAS GK, Weiss A, Constant BD, Parlett LE, et al
Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.
Inflamm Bowel Dis. 2023 Apr 12:izad053. doi: 10.1093.
PubMed Abstract available

YERUSHALMY-FELER A, Olbjorn C, Kolho KL, Aloi M, et al
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Inflamm Bowel Dis. 2023 Apr 12:izad064. doi: 10.1093.
PubMed Abstract available

KILIC Y, Kamal S, Jaffar F, Sriranganathan D, et al
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Apr 12:izad061. doi: 10.1093.
PubMed Abstract available

LOLY JP, Vieujean S, Reenaers C, Van Kemseke C, et al
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab.
Inflamm Bowel Dis. 2023 Apr 12:izad066. doi: 10.1093.
PubMed Abstract available

TSE CS, Weng CH, Kwon M, Wolk CB, et al
Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017.
Inflamm Bowel Dis. 2023 Apr 7:izad062. doi: 10.1093.
PubMed

CHEN D, Tang H, Li Y, Yang H, et al
Vitamin D3 and Lactobacillus rhamnosus GG/p40 Synergize to Protect Mice From Colitis by Promoting Vitamin D Receptor Expression and Epithelial Proliferation.
Inflamm Bowel Dis. 2023;29:620-632.
PubMed Abstract available

ASHTON JJ, Cheng G, Stafford IS, Kellermann M, et al
Prediction of Crohn's Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker.
Inflamm Bowel Dis. 2023;29:511-521.
PubMed Abstract available

NOOR NM, Lee JC
The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity.
Inflamm Bowel Dis. 2023;29:669-671.
PubMed

HOLMER AK, Boland BS, Singh S, Neill J, et al
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023;29:555-562.
PubMed Abstract available

PARK J, Chun J, Yoon H, Cheon JH, et al
Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study.
Inflamm Bowel Dis. 2023;29:548-554.
PubMed Abstract available

RISPO A, de Sire R, Mainenti PP, Imperatore N, et al
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease.
Inflamm Bowel Dis. 2023;29:563-569.
PubMed Abstract available

D'AMICO F, Tasopoulou O, Fiorino G, Zilli A, et al
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
Inflamm Bowel Dis. 2023;29:539-547.
PubMed Abstract available

VUYYURU SK, Nguyen TM, Hogan M, Raine T, et al
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Apr 1:izad052. doi: 10.1093.
PubMed Abstract available

March 2023

DENG L, He S, Li Y, Ding R, et al
Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Mar 31:izad050. doi: 10.1093.
PubMed Abstract available

DERKS MEW, van Lierop LMA, Te Groen M, Kuijpers CCHJ, et al
Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update.
Inflamm Bowel Dis. 2023 Mar 31:izad055. doi: 10.1093.
PubMed

TANDON P, Chhibba T, Natt N, Singh Brar G, et al
Significant Racial and Ethnic Disparities Exist in Health Care Utilization in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Mar 28:izad045. doi: 10.1093.
PubMed Abstract available

AKIYA A, Takahashi K, Akimoto S, Hosono Y, et al
Novel Findings of Early Cardiac Dysfunction in Patients With Childhood-Onset Inflammatory Bowel Disease Using Layer-Specific Strain Analysis.
Inflamm Bowel Dis. 2023 Mar 27:izad031. doi: 10.1093.
PubMed Abstract available

ANYANE-YEBOA A, Buadu MAE, Khalili H, Cozier YC, et al
Epidemiology of Inflammatory Bowel Disease in a Cohort of US Black Women.
Inflamm Bowel Dis. 2023 Mar 22:izad049. doi: 10.1093.
PubMed Abstract available

LU X, Zhou ZY, Xin Y, Wang MJ, et al
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Mar 22:izad037. doi: 10.1093.
PubMed Abstract available

KAYAL M, Posner H, Milwidsky HM, Plietz M, et al
Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis.
Inflamm Bowel Dis. 2023 Mar 20:izad039. doi: 10.1093.
PubMed Abstract available

RABINOWITZ LG
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.
Inflamm Bowel Dis. 2023 Mar 18:izad047. doi: 10.1093.
PubMed

COLLEN LV
Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn's Disease.
Inflamm Bowel Dis. 2023 Mar 18:izad048. doi: 10.1093.
PubMed

GOODSALL TM, Day AS, Andrews JM, Ruszkiewicz A, et al
Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study.
Inflamm Bowel Dis. 2023 Mar 16:izad043. doi: 10.1093.
PubMed Abstract available

MARRIE RA, Fisk JD, Dolovich C, Lix LM, et al
Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 14:izad038. doi: 10.1093.
PubMed Abstract available

VARMA S, Trudeau SJ, Li J, Freedberg DE, et al
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Inflamm Bowel Dis. 2023 Mar 14:izad035. doi: 10.1093.
PubMed Abstract available

BUIE MJ, Coward S, Shaheen AA, Holroyd-Leduc J, et al
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.
Inflamm Bowel Dis. 2023 Mar 14:izad020. doi: 10.1093.
PubMed Abstract available

AGOSTINI A, Benuzzi F, Ballotta D, Rizzello F, et al
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages.
Inflamm Bowel Dis. 2023 Mar 10:izad029. doi: 10.1093.
PubMed Abstract available

ALMOMEN HS, Al-Bawardy B
Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation.
Inflamm Bowel Dis. 2023 Mar 8:izad040. doi: 10.1093.
PubMed

LIU R, Li Z, Ye L, Hu J, et al
Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn's Disease on Ustekinumab: A Nationwide Real-World Study.
Inflamm Bowel Dis. 2023 Mar 6:izad032. doi: 10.1093.
PubMed Abstract available

KUNISAKI R, Ikeda A, Yaguchi K, Onishi M, et al
To Be in Remission or in Corticosteroid-free Remission: That Is the Question for Women With Inflammatory Bowel Disease at Conception.
Inflamm Bowel Dis. 2023 Mar 6:izad023. doi: 10.1093.
PubMed

MOURAD FH, Maalouf RG, Aoun R, Gustavo Kotze P, et al
Are the New Biologics Effective in the Management of Postoperative Crohn's Disease?
Inflamm Bowel Dis. 2023 Mar 4:izad033. doi: 10.1093.
PubMed Abstract available

SCHROEDER MK, Tan SA, Touma MJ, Basit M, et al
Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions.
Inflamm Bowel Dis. 2023 Mar 2:izad026. doi: 10.1093.
PubMed

CHIBA M, Hosoba M, Yamada K
Plant-Based Diet Recommended for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 1:izac279. doi: 10.1093.
PubMed

LIMKETKAI BN
Reply: Plant-Based Diet Recommended for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 1:izad022. doi: 10.1093.
PubMed

GEERTSEMA S, Otten AT, Bouwknegt DG, Visschedijk MC, et al
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:e10-e11.
PubMed

MASSELOT CR, Cordier C, Marsac B, Nachury M, et al
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:e12.
PubMed

CHIRRA P, Sharma A, Bera K, Cohn HM, et al
Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study.
Inflamm Bowel Dis. 2023;29:349-358.
PubMed Abstract available

MCKENNA NP, Kelley SR, Bews KA, Behm KT, et al
Surgical Management of Enterovesical Fistula in Crohn's Disease in the Biologic Era.
Inflamm Bowel Dis. 2023;29:480-482.
PubMed

GU P, Dube S, McGovern DPB
Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature.
Inflamm Bowel Dis. 2023;29:458-469.
PubMed Abstract available

SHEHAB M, Alrashed F, Heron V, Restellini S, et al
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Inflamm Bowel Dis. 2023;29:367-375.
PubMed Abstract available

TURSI A, Mocci G, Allegretta L, Aragona G, et al
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Inflamm Bowel Dis. 2023;29:376-383.
PubMed Abstract available

KASSIM G, Yzet C, Nair N, Debebe A, et al
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.
Inflamm Bowel Dis. 2023;29:417-422.
PubMed Abstract available

February 2023

AYOUB M, Shah H, Nguyen BC, Mehdi M, et al
Coronary Artery Plaque Assessment by CT Angiogram in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Feb 24:izad036. doi: 10.1093.
PubMed

URQUHART SA, Comstock BP, Jin MF, Day CN, et al
The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Feb 22:izad021. doi: 10.1093.
PubMed Abstract available

AL-BAWARDY B, Malter L, Ehrlich AC, Rieder F, et al
Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows.
Inflamm Bowel Dis. 2023 Feb 22:izad030. doi: 10.1093.
PubMed

BURSTINER LS, Owings AH, Royer A, Hreish Y, et al
Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.
Inflamm Bowel Dis. 2023 Feb 21:izad005. doi: 10.1093.
PubMed Abstract available

VALVANO M, Vinci A, Latella G
Reply: Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Feb 17:izad028. doi: 10.1093.
PubMed

DAI C, Huang YH
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Feb 17:izad025. doi: 10.1093.
PubMed

BRAMUZZO M, Giudici F, Arrigo S, Lionetti P, et al
Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Feb 17:izad018. doi: 10.1093.
PubMed Abstract available

CARTER D, Albshesh A, Shimon C, Segal B, et al
Automatized Detection of Crohn's Disease in Intestinal Ultrasound Using Convolutional Neural Network.
Inflamm Bowel Dis. 2023 Feb 16:izad014. doi: 10.1093.
PubMed Abstract available

SINGH N, Nugent Z, Singh H, Shaffer SR, et al
Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Feb 15:izad017. doi: 10.1093.
PubMed Abstract available

DANESE S, Tran J, D'Haens G, Rubin DT, et al
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Inflamm Bowel Dis. 2023 Feb 15:izad016. doi: 10.1093.
PubMed Abstract available

CALDERA F, Richard L, Almasry M, Phan H, et al
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Feb 15:izad019. doi: 10.1093.
PubMed

YOUSSEF M, Dong K, Lee SJ, Narula N, et al
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Feb 8:izad013. doi: 10.1093.
PubMed Abstract available

LOVEIKYTE R, Bourgonje AR, van der Reijden JJ, Bulthuis MLC, et al
Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab.
Inflamm Bowel Dis. 2023 Feb 7:izad010. doi: 10.1093.
PubMed Abstract available

HORRIGAN J, Tadros M
Novel Patient-centered Educational Panel Enhances Preclinical Medical Student Understanding of IBD Beyond What Can Be Learned in a Traditional Classroom.
Inflamm Bowel Dis. 2023;29:e3-e4.
PubMed

JELINSKY SA, Derksen M, Bauman E, Verissimo CS, et al
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
Inflamm Bowel Dis. 2023;29:195-206.
PubMed Abstract available

JACOBS J, Clark-Snustad K, Lee S
Deep Remission in Severe Refractory Crohn's Disease With Mycophenolate Mofetil.
Inflamm Bowel Dis. 2023;29:332-333.
PubMed

MADDIPATLA SC, Kolachala VL, Venkateswaran S, Dodd AF, et al
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naive and Treated Crohn's Disease.
Inflamm Bowel Dis. 2023;29:274-285.
PubMed Abstract available

KAWAMURA T, Yamamura T, Nakamura M, Maeda K, et al
Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
Inflamm Bowel Dis. 2023;29:245-253.
PubMed Abstract available

ZACHAROPOULOU E, Orfanoudaki E, Tzouvala M, Tribonias G, et al
Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
Inflamm Bowel Dis. 2023;29:228-237.
PubMed Abstract available

BUISSON A, Blanco L, Manlay L, Reymond M, et al
Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn's Disease.
Inflamm Bowel Dis. 2023;29:185-194.
PubMed Abstract available

January 2023

LI C, Xu Y, Gao T, Zhang S, et al
Ruxolitinib Alleviates Inflammation, Apoptosis, and Intestinal Barrier Leakage in Ulcerative Colitis via STAT3.
Inflamm Bowel Dis. 2023 Jan 31:izad007. doi: 10.1093.
PubMed Abstract available

ERTEM FU, Rivers CR, Watson AR, Tang G, et al
Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn's Disease.
Inflamm Bowel Dis. 2023 Jan 31:izad008. doi: 10.1093.
PubMed Abstract available

SALVATORI S, Monteleone G
Reply: Frail Phenotype in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jan 31:izad015. doi: 10.1093.
PubMed

SEMPERE L, Bernabeu P, Cameo J, Gutierrez A, et al
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.
Inflamm Bowel Dis. 2023 Jan 31:izad001. doi: 10.1093.
PubMed Abstract available

CHOI DK, Cohen NA, Choden T, Cohen RD, et al
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jan 30:izad012. doi: 10.1093.
PubMed

GISBERT JP, Parody-Rua E, Chaparro M
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review.
Inflamm Bowel Dis. 2023 Jan 28:izac275. doi: 10.1093.
PubMed Abstract available

SHU W, Wang Y, Li C, Zhang L, et al
Single-cell Expression Atlas Reveals Cell Heterogeneity in the Creeping Fat of Crohn's Disease.
Inflamm Bowel Dis. 2023 Jan 28:izac266. doi: 10.1093.
PubMed Abstract available

DI MARTINO L, Osme A, Ghannoum M, Cominelli F, et al
A Novel Probiotic Combination Ameliorates Crohn's Disease-Like Ileitis by Increasing Short-Chain Fatty Acid Production and Modulating Essential Adaptive Immune Pathways.
Inflamm Bowel Dis. 2023 Jan 28:izac284. doi: 10.1093.
PubMed Abstract available

PHAN H, Hayney MS, Caldera F
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".
Inflamm Bowel Dis. 2023 Jan 28:izad006. doi: 10.1093.
PubMed

GANTZEL RH, Vesterdal JD, Haase AM, Petersen AJ, et al
The Prevalence of Inflammatory Bowel Disease in Greenland.
Inflamm Bowel Dis. 2023 Jan 25:izad002. doi: 10.1093.
PubMed Abstract available

YOKOSE S, Murono K, Nozawa H, Sasaki K, et al
Preoperative Simulation of Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis Using a 3-Dimensional Printed Model.
Inflamm Bowel Dis. 2023 Jan 23:izac283. doi: 10.1093.
PubMed Abstract available

JEONG J, Walters TD, Huynh HQ, Lawrence S, et al
Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent.
Inflamm Bowel Dis. 2023 Jan 23:izac276. doi: 10.1093.
PubMed Abstract available

BASSON AR, Katz J, Singh S, Celio F, et al
Sweets and Inflammatory Bowel Disease: Patients Favor Artificial Sweeteners and Diet Foods/Drinks Over Table Sugar and Consume Less Fruits/Vegetables.
Inflamm Bowel Dis. 2023 Jan 21:izac272. doi: 10.1093.
PubMed Abstract available

FERRU-CLEMENT R, Boucher G, Forest A, Bouchard B, et al
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease.
Inflamm Bowel Dis. 2023 Jan 20:izac281. doi: 10.1093.
PubMed Abstract available

PANES J, Loftus EV, Higgins PDR, Lindsay JO, et al
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results.
Inflamm Bowel Dis. 2023 Jan 16:izac260. doi: 10.1093.
PubMed Abstract available

IKEDA A, Kunisaki R, Aoki S, Yaguchi K, et al
Appropriate Preconception Corticosteroid-Free Remission Period in Pregnant Women With Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Jan 14:izac270. doi: 10.1093.
PubMed Abstract available

GHIBOUB M, Boneh RS, Sovran B, Wine E, et al
Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways.
Inflamm Bowel Dis. 2023 Jan 13:izac262. doi: 10.1093.
PubMed Abstract available

BARBERIO B, Gracie DJ, Black CJ, Ford AC, et al
Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis.
Inflamm Bowel Dis. 2023 Jan 13:izac263. doi: 10.1093.
PubMed Abstract available

BOKEMEYER B, Plachta-Danielzik S, di Giuseppe R, Mohl W, et al
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Inflamm Bowel Dis. 2023 Jan 12:izac271. doi: 10.1093.
PubMed Abstract available

LIN WC, Tai WC, Chang CH, Tu CH, et al
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
Inflamm Bowel Dis. 2023 Jan 10:izac269. doi: 10.1093.
PubMed Abstract available

YANG Y, Ludvigsson JF, Olen O, Sjolander A, et al
Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based Study.
Inflamm Bowel Dis. 2023 Jan 7:izac267. doi: 10.1093.
PubMed Abstract available

FUENTES-VALENZUELA E, Garcia-Alonso FJ, Maroto-Martin C, Juan Casamayor L, et al
Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Jan 7:izac259. doi: 10.1093.
PubMed Abstract available

KURDI AT, Noor NM, Gold SL
IBD Journal Editorial Fellowship: A Practical Guide for Future Fellows.
Inflamm Bowel Dis. 2023;29:172-173.
PubMed

ROBBE MASSELOT C, Cordier C, Marsac B, Nachury M, et al
Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:167-171.
PubMed

MANSKI SA, Schlachterman A
Bypass of a Duodenal Stricture in Crohn's Disease Using a Lumen Opposing Metal Stent (LAMS): A Case Report.
Inflamm Bowel Dis. 2023;29:177-178.
PubMed

WEI S, Zhang J, Wu X, Chen M, et al
Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis.
Inflamm Bowel Dis. 2023;29:9-26.
PubMed Abstract available

LIU Q, Wang D, Yang X, Ma F, et al
The Mechanosensitive Ion Channel PIEZO1 in Intestinal Epithelial Cells Mediates Inflammation through the NOD-Like Receptor 3 Pathway in Crohn's Disease.
Inflamm Bowel Dis. 2023;29:103-115.
PubMed Abstract available

KHOSRAVI B, Salehnia A, Pak N, Montazeri SA, et al
A Practical Index to Distinguish Backwash Ileitis From Crohn's Terminal Ileitis in MR Enterography.
Inflamm Bowel Dis. 2023;29:42-50.
PubMed Abstract available

CORRIDONI D, Pizarro TT
Single-cell Transcriptomics Reveal the Importance of Distinct Epithelial Cell Populations in Ileal-specific, Treatment-naive, and Treated Crohn's Disease Patients.
Inflamm Bowel Dis. 2023 Jan 4:izac264. doi: 10.1093.
PubMed

PODDAR U, Aggarwal A, Jayalakshmi K, Sarma MS, et al
Higher Prevalence of Monogenic Cause Among Very Early Onset Inflammatory Bowel Disease in Children: Experience From a Tertiary Care Center From Northern India.
Inflamm Bowel Dis. 2023 Jan 3:izac254. doi: 10.1093.
PubMed Abstract available

December 2022

VALVANO M, Magistroni M, Cesaro N, Carlino G, et al
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis.
Inflamm Bowel Dis. 2022 Dec 29:izac253. doi: 10.1093.
PubMed Abstract available

MUNGMUNPUNTIPANTIP R, Wiwanitkit V
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.
Inflamm Bowel Dis. 2022 Dec 29:izac257. doi: 10.1093.
PubMed

Correction to: The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Dec 28:izac258. doi: 10.1093.
PubMed

DESAI A, Deepak P, Cross RK, Murone J, et al
Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis.
Inflamm Bowel Dis. 2022 Dec 28:izac252. doi: 10.1093.
PubMed Abstract available

TONG JKC, Mascuilli T, Wirtalla C, Aarons CB, et al
Evaluating Changes in Surgical Outcomes for Patients With Inflammatory Bowel Disease Following Medicaid Expansion.
Inflamm Bowel Dis. 2022 Dec 27:izac255. doi: 10.1093.
PubMed Abstract available

ALFAIFI J, Germain A, Heba AC, Arnone D, et al
Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Dec 21:izac250. doi: 10.1093.
PubMed Abstract available

WANG J, Macoritto M, Guay H, Davis JW, et al
The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-alpha Inadequate Response Mechanisms.
Inflamm Bowel Dis. 2022 Dec 14:izac246. doi: 10.1093.
PubMed Abstract available

POKROTNIEKS J, Sitkin S
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma.
Inflamm Bowel Dis. 2022 Dec 14:izac248. doi: 10.1093.
PubMed

SHIH T, Yusung S, Gonsky R, Dutra-Clarke R, et al
Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location.
Inflamm Bowel Dis. 2022 Dec 12:izac251. doi: 10.1093.
PubMed

BOMMENA S, Goldberg A, Amini M, Alishahi Y, et al
Depression in Women With Inflammatory Bowel Disease: A Multifaceted Approach for a Multidimensional Problem.
Inflamm Bowel Dis. 2022 Dec 6:izac245. doi: 10.1093.
PubMed Abstract available

SALVATORI S, Marafini I, Venuto C, Laudisi F, et al
Frail Phenotype in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Dec 2:izac242. doi: 10.1093.
PubMed Abstract available

ABREU MT, Davies JM, Quintero MA, Delmas A, et al
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
Inflamm Bowel Dis. 2022;28:1800-1812.
PubMed Abstract available

MORGAN NN, Duck LW, Wu J, Rujani M, et al
Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
Inflamm Bowel Dis. 2022;28:1893-1903.
PubMed Abstract available

HONG SJ, Zenger C, Pecoriello J, Pang A, et al
Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy.
Inflamm Bowel Dis. 2022;28:1826-1832.
PubMed Abstract available

DAWSON R, Wands DIF, Logan M, Bremner G, et al
Comparing Effectiveness of a Generic Oral Nutritional Supplement With Specialized Formula in the Treatment of Active Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1859-1864.
PubMed Abstract available

PAN Y, Ahmed W, Mahtani P, Wong R, et al
Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1865-1871.
PubMed Abstract available

BROWN SC, Whelan K, Frampton C, Wall CL, et al
Food-Related Quality of Life in Children and Adolescents With Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1838-1843.
PubMed Abstract available

SASIDHARAN S, Sasson AN, Shannon KM, Ananthakrishnan AN, et al
Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis.
Inflamm Bowel Dis. 2022;28:1833-1837.
PubMed Abstract available

November 2022

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.
Inflamm Bowel Dis. 2022 Nov 25:izac231. doi: 10.1093.
PubMed Abstract available

CHEN K, Chen J, Smith E, Mathani P, et al
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.
Inflamm Bowel Dis. 2022 Nov 24:izac236. doi: 10.1093.
PubMed

COLMAN RJ, Samuels A, Mizuno T, Punt N, et al
Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Nov 22:izac237. doi: 10.1093.
PubMed

Correction to: Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Nov 18. pii: 6832530. doi: 10.1093.
PubMed

POLAT G, Kani HT, Ergenc I, Ozen Alahdab Y, et al
Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning.
Inflamm Bowel Dis. 2022 Nov 16. pii: 6830946. doi: 10.1093.
PubMed Abstract available

YOGEV D, Verstockt B, Dignass A, Focht G, et al
The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease.
Inflamm Bowel Dis. 2022 Nov 9:izac235. doi: 10.1093.
PubMed

LICHTENSTEIN GR, Bressler B, Francisconi C, Vermeire S, et al
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis. 2022 Nov 7. pii: 6808367. doi: 10.1093.
PubMed Abstract available

SHIMOYAMA T, Yamamoto T, Yoshiyama S, Nishikawa R, et al
Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Nov 5. pii: 6804445. doi: 10.1093.
PubMed Abstract available

RAMOS L, Hernandez-Porto M, Carrillo-Palau M, Alonso-Abreu I, et al
Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2022 Nov 2. pii: 6793895. doi: 10.1093.
PubMed

SCHWEDA A, Becker E, Wiendl M, Atreya R, et al
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells.
Inflamm Bowel Dis. 2022;28:1746-1755.
PubMed Abstract available

DALAL RS, Bains K, Marcus J, McClure EL, et al
Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series.
Inflamm Bowel Dis. 2022;28:1787-1789.
PubMed

KREISS L, Thoma OM, Lemire S, Lechner K, et al
Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging.
Inflamm Bowel Dis. 2022;28:1637-1646.
PubMed Abstract available

XU L, Huang G, Cong Y, Yu Y, et al
Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones.
Inflamm Bowel Dis. 2022;28:1766-1775.
PubMed Abstract available

MAHMUD N, Shah Y, Khan N
Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients.
Inflamm Bowel Dis. 2022;28:1776-1780.
PubMed

CHAPARRO M, Baston-Rey I, Fernandez-Salgado E, Gonzalez Garcia J, et al
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Inflamm Bowel Dis. 2022;28:1725-1736.
PubMed Abstract available

ATTAUABI M, Wewer MD, Bendtsen F, Seidelin JB, et al
Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
Inflamm Bowel Dis. 2022;28:1756-1765.
PubMed Abstract available

PANES J, Bouma G, Ferrante M, Kucharzik T, et al
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
Inflamm Bowel Dis. 2022;28:1737-1745.
PubMed Abstract available

LIMKETKAI BN, Hamideh M, Shah R, Sauk JS, et al
Dietary Patterns and Their Association With Symptoms Activity in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:1627-1636.
PubMed Abstract available

INOUE A, Bartlett DJ, Shahraki N, Sheedy SP, et al
Predicting Risk of Surgery in Patients With Small Bowel Crohn's Disease Strictures Using Computed Tomography and Magnetic Resonance Enterography.
Inflamm Bowel Dis. 2022;28:1677-1686.
PubMed Abstract available

SAVELKOUL EHJ, Thomas PWA, Derikx LAAP, den Broeder N, et al
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Nov 1. pii: 6786024. doi: 10.1093.
PubMed Abstract available

October 2022

BOYD T, Friedman S
Challenges and Opportunities for Advancing Research and Improving Care for Sexual and Gender Minorities With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Oct 29. pii: 6779855. doi: 10.1093.
PubMed

GOLD SL, Manning L, Kohler D, Ungaro R, et al
Micronutrients and Their Role in Inflammatory Bowel Disease: Function, Assessment, Supplementation, and Impact on Clinical Outcomes Including Muscle Health.
Inflamm Bowel Dis. 2022 Oct 26. pii: 6774890. doi: 10.1093.
PubMed

SCOTT FI, Ehrlich O, Wood D, Viator C, et al
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.
Inflamm Bowel Dis. 2022 Oct 22. pii: 6769932. doi: 10.1093.
PubMed Abstract available

AHMED W, Billing W, Stump TE, Strobel T, et al
Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study.
Inflamm Bowel Dis. 2022 Oct 22. pii: 6769933. doi: 10.1093.
PubMed Abstract available

BIEDERMANN L, Dubinsky MC, Vermeire S, Fellmann M, et al
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
Inflamm Bowel Dis. 2022 Oct 15. pii: 6761656. doi: 10.1093.
PubMed Abstract available

BREUGELMANS T, Arras W, Boen LE, Borms E, et al
Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity.
Inflamm Bowel Dis. 2022 Oct 14. pii: 6761121. doi: 10.1093.
PubMed Abstract available

LUTZ M, Hayney MS, Farraye FA, Caldera F, et al
A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Oct 6. pii: 6749562. doi: 10.1093.
PubMed

JORDI SBU, Begre S, Misselwitz B
Should a Psychologist Be a Mandatory Component of IBD Consults? Yes-Authors' Reply.
Inflamm Bowel Dis. 2022;28:e138-e139.
PubMed

CHEN HM, MacDonald JA
Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
Inflamm Bowel Dis. 2022;28:1485-1496.
PubMed Abstract available

ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study.
Inflamm Bowel Dis. 2022;28:1618-1622.
PubMed

LUPU G, Weaver KN, Herfarth HH, Barnes EL, et al
Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
Inflamm Bowel Dis. 2022;28:1610-1613.
PubMed

SANTIAGO M, Dias CC, Alves C, Ministro P, et al
The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review.
Inflamm Bowel Dis. 2022;28:1527-1536.
PubMed Abstract available

ADLER J, Eder SJ, Gebremariam A, Moran CJ, et al
Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1537-1542.
PubMed Abstract available

TSAI L, McCurdy JD, Ma C, Jairath V, et al
Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.
Inflamm Bowel Dis. 2022;28:1477-1484.
PubMed Abstract available

September 2022

VUYYURU SK, Brahmania M, Arab JP, Jairath V, et al
Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy.
Inflamm Bowel Dis. 2022 Sep 29. pii: 6731264. doi: 10.1093.
PubMed

SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
Reply to "Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy".
Inflamm Bowel Dis. 2022 Sep 29. pii: 6731245. doi: 10.1093.
PubMed

TANNER S, Katz J, Cominelli F, Regueiro M, et al
Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?
Inflamm Bowel Dis. 2022 Sep 28. pii: 6726164. doi: 10.1093.
PubMed

MULES TC, Swaminathan A, Hirschfeld E, Borichevsky GM, et al
The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Sep 27. pii: 6724308. doi: 10.1093.
PubMed Abstract available

TANAKA M, Kawakami A, Sakagami K, Terai T, et al
Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.
Inflamm Bowel Dis. 2022 Sep 27. pii: 6723730. doi: 10.1093.
PubMed Abstract available

VAN WASSENAER EA, van Rijn RR, Zwetsloot SLM, de Voogd FAE, et al
Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices.
Inflamm Bowel Dis. 2022 Sep 23. pii: 6712311. doi: 10.1093.
PubMed Abstract available

BAKHSHI Z, Yadav S, Harmsen WS, Edakkanambeth Varayil J, et al
Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes.
Inflamm Bowel Dis. 2022 Sep 23. pii: 6712289. doi: 10.1093.
PubMed Abstract available

CHOI B, Sey M, Ponich T, Beaton M, et al
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype.
Inflamm Bowel Dis. 2022 Sep 16. pii: 6702271. doi: 10.1093.
PubMed Abstract available

ABDEL-RAHMAN LIH, Morgan XC
Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis.
Inflamm Bowel Dis. 2022 Sep 16. pii: 6702269. doi: 10.1093.
PubMed Abstract available

CALDERA F, Farraye FA, Necela BM, Cogen D, et al
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
Inflamm Bowel Dis. 2022 Sep 14. pii: 6697965. doi: 10.1093.
PubMed Abstract available

MACEDO SILVA V, Lima Capela T, Freitas M, Curdia Goncalves T, et al
Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
Inflamm Bowel Dis. 2022 Sep 13. pii: 6696695. doi: 10.1093.
PubMed Abstract available

CROUWEL F, Simsek M, van Doorn AS, Mulder CJJ, et al
Rectally Administrated Thioguanine for Distal Ulcerative Colitis: A Multicenter Case Series.
Inflamm Bowel Dis. 2022 Sep 13. pii: 6696694. doi: 10.1093.
PubMed

NARKIS B, Hadar E, Barbash-Hazan S, Houri O, et al
Peripartum Infections Among Women With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Sep 1. pii: 6682832. doi: 10.1093.
PubMed Abstract available

MARION L, Amelie B, Zoubir D, Guillaume C, et al
Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
Inflamm Bowel Dis. 2022;28:1395-1404.
PubMed Abstract available

HANZEL J, Sedano R, Jeyarajah J, Zou G, et al
Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn's Disease: Systematic Review and Meta-Regression.
Inflamm Bowel Dis. 2022;28:1462-1464.
PubMed

CARTER D, Ben-Horin S, Horesh N, Saukhat O, et al
Ultrasound-Tomographic Image Fusion: A Novel Imaging Technique for Follow-Up of Penetrating Complications of Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1451-1453.
PubMed Abstract available

PICORARO JA, Shen B
The Pediatric Pouch Deserves Precision.
Inflamm Bowel Dis. 2022;28:1469-1471.
PubMed

DUBINSKY MC, Mendiolaza ML, Phan BL, Moran HR, et al
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.
Inflamm Bowel Dis. 2022;28:1375-1385.
PubMed Abstract available

CHIN KOON SIW K, Engel J, Visva S, Mallick R, et al
Strategies to Distinguish Perianal Fistulas Related to Crohn's Disease From Cryptoglandular Disease: Systematic Review With Meta-Analysis.
Inflamm Bowel Dis. 2022;28:1363-1374.
PubMed Abstract available

HANZEL J, Jairath V, De Cruz P, Guizzetti L, et al
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1321-1331.
PubMed Abstract available

August 2022

HOYHTYA M, Korpela K, Saqib S, Junkkari S, et al
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 30. pii: 6679143. doi: 10.1093.
PubMed Abstract available

VAUGHAN R, Murphy E, Nalder M, Gibson RN, et al
Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 27. pii: 6696163. doi: 10.1093.
PubMed Abstract available

WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2022 Aug 26. pii: 6677128. doi: 10.1093.
PubMed

ALENEZY N, Nugent Z, Herman S, Zaborniak K, et al
Aeroallergen-related Diseases Predate the Diagnosis of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 26. pii: 6677127. doi: 10.1093.
PubMed Abstract available

DAI C, Huang YH
The Role of Appendicectomy in Ulcerative Colitis: True or Coincidental Association?
Inflamm Bowel Dis. 2022 Aug 24. pii: 6674531. doi: 10.1093.
PubMed

YU N, Basnayake C
Vaccinations for Patients With Inflammatory Bowel Disease in Primary Care: An Opportunity for Improvement.
Inflamm Bowel Dis. 2022 Aug 23. pii: 6674008. doi: 10.1093.
PubMed

LI D, Debbas P, Mujukian A, Cheng S, et al
Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD.
Inflamm Bowel Dis. 2022 Aug 23. pii: 6673996. doi: 10.1093.
PubMed Abstract available

KIM C, Yin Z, Kamdar N, Stidham R, et al
Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children.
Inflamm Bowel Dis. 2022 Aug 20. pii: 6672842. doi: 10.1093.
PubMed Abstract available

ODUFALU FD
Editorial: Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Aug 20. pii: 6672843. doi: 10.1093.
PubMed

HELLMANN J, Ta A, Ollberding NJ, Bezold R, et al
Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 16. pii: 6668484. doi: 10.1093.
PubMed Abstract available

KUMAR S, Pollok R, Goldsmith D
Renal and Urological Disorders Associated With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 9. pii: 6658535. doi: 10.1093.
PubMed Abstract available

ALOI M, D'Arcangelo G, Rossetti D, Bucherini S, et al
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Aug 9. pii: 6658537. doi: 10.1093.
PubMed Abstract available

NAROUS M, Nugent Z, Singh H, Bernstein CN, et al
Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
Inflamm Bowel Dis. 2022 Aug 5. pii: 6656176. doi: 10.1093.
PubMed Abstract available

YANG JY, Lund JL, Pate V, Kappelman MD, et al
Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019.
Inflamm Bowel Dis. 2022 Aug 5. pii: 6656175. doi: 10.1093.
PubMed Abstract available

SOOD A, Singh A, Mahajan R, Midha V, et al
(Re)Appraising Remission in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Aug 2. pii: 6653351. doi: 10.1093.
PubMed Abstract available

GREYWOODE R, Petralia F, Ullman TA, Frederic Colombel J, et al
Racial Difference in Efficacy of Golimumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Aug 1. pii: 6652811. doi: 10.1093.
PubMed Abstract available

LIBERTUCCI J, Dutta U, Armstrong D
Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients.
Inflamm Bowel Dis. 2022;28:e120.
PubMed

OLAISEN M, Fossmark R
Reply to "Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients".
Inflamm Bowel Dis. 2022;28:e121.
PubMed

BICKSTON SJ, Patrone MV
Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:1296-1297.
PubMed

BLAISDELL A, Zhou Y, Kattah MG, Fisher SJ, et al
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
Inflamm Bowel Dis. 2022;28:1219-1228.
PubMed Abstract available

HE S, Azar DA, Esfahani FN, Azar GA, et al
Mechanoscopy: A Novel Device and Procedure for in vivo Detection of Chronic Colitis in Mice.
Inflamm Bowel Dis. 2022;28:1143-1150.
PubMed Abstract available

DAHAR MM, Ramos Rivers C, Ahsan M, Johnston E, et al
Positive Gluten Sensitivity Serologies and the Impact of Gluten-free Diet in Patients With IBD.
Inflamm Bowel Dis. 2022;28:e122-e123.
PubMed

MOENS A, Verstockt B, Alsoud D, Sabino J, et al
Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.
Inflamm Bowel Dis. 2022;28:1135-1142.
PubMed Abstract available

ROBLIN X, Serone A, Yoon OK, Zhuo L, et al
Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.
Inflamm Bowel Dis. 2022;28:1207-1218.
PubMed Abstract available

EVERHOV AH, Kalman TD, Soderling J, Nordenvall C, et al
Probability of Stoma in Incident Patients With Crohn's Disease in Sweden 2003-2019: A Population-based Study.
Inflamm Bowel Dis. 2022;28:1160-1168.
PubMed Abstract available

NOOR NM, Sousa P, Paul S, Roblin X, et al
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.
Inflamm Bowel Dis. 2022;28:1254-1264.
PubMed Abstract available

July 2022

TAFT TH, McGarva J, Omprakash TA, Tomasino K, et al
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
Inflamm Bowel Dis. 2022 Jul 27. pii: 6650637. doi: 10.1093.
PubMed Abstract available

GLYNN H, Mikocka-Walus A, Knowles SR
Editorial: Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
Inflamm Bowel Dis. 2022 Jul 27. pii: 6650636. doi: 10.1093.
PubMed

GRANT RK, Brindle WM, Arnott IDR
The Value of a Dedicated IBD Flare Clinic to Effectively Manage Exacerbations of Inflammatory Bowel Disease: The Edinburgh IBD Unit.
Inflamm Bowel Dis. 2022 Jul 22. pii: 6648508. doi: 10.1093.
PubMed

HSU C, Ghannoum M, Cominelli F, Martino LD, et al
Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies.
Inflamm Bowel Dis. 2022 Jul 19. pii: 6646155. doi: 10.1093.
PubMed Abstract available

Correction to: Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
Inflamm Bowel Dis. 2022 Jul 18. pii: 6645873. doi: 10.1093.
PubMed

CROSBY S, Schuh MJ, Becker M, Ivanov M, et al
New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jul 13. pii: 6643251. doi: 10.1093.
PubMed Abstract available

WEAVER KN, Zhang X, Dai X, Chen W, et al
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jul 13. pii: 6643250. doi: 10.1093.
PubMed

LIU JJ, Abraham BP, Adamson P, Barnes EL, et al
The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2022 Jul 11. pii: 6639794. doi: 10.1093.
PubMed Abstract available

BUISSON A, Serrero M, Orsat L, Nancey S, et al
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflamm Bowel Dis. 2022 Jul 11. pii: 6639655. doi: 10.1093.
PubMed Abstract available

SHARMA N
Should a Psychologist Be a Mandatory Component of Inflammatory Bowel Disease Consults? Yes.
Inflamm Bowel Dis. 2022 Jul 6. pii: 6632462. doi: 10.1093.
PubMed

LOFTUS EV, Baumgart DC, Gecse K, Kinnucan JA, et al
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.
Inflamm Bowel Dis. 2022 Jul 6. pii: 6632473. doi: 10.1093.
PubMed Abstract available

YUAN W, Marwaha JS, Rakowsky ST, Palmer NP, et al
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis.
Inflamm Bowel Dis. 2022 Jul 4. pii: 6628670. doi: 10.1093.
PubMed Abstract available

XU F, deJong N, Kappelman MD, Greenlund KJ, et al
Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jul 2. pii: 6627525. doi: 10.1093.
PubMed Abstract available

SAFARPOUR AR, Shojaei-Zarghani S, Mehrabi M, Keshtkar AA, et al
Alterations in the Course of Inflammatory Bowel Disease Following Liver Transplantation: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2022 Jul 2. pii: 6627524. doi: 10.1093.
PubMed Abstract available

HOLMGREN J, Froborg A, Visuri I, Halfvarson J, et al
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2022 Jul 1. pii: 6625867. doi: 10.1093.
PubMed Abstract available

GONZALEZ-BERNARDO O, Riestra S
Reply to "Virtual Chromoendoscopy vs High-definition White Light Endoscopy Using iSCAN".
Inflamm Bowel Dis. 2022;28:e107.
PubMed

JURICKOVA I, Bonkowski E, Angerman E, Novak E, et al
Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures.
Inflamm Bowel Dis. 2022;28:988-1003.
PubMed Abstract available

WEAVER KN, Herfarth HH, Barnes EL
Antibiotic Use Patterns in the Management of Chronic Pouchitis.
Inflamm Bowel Dis. 2022;28:e92-e93.
PubMed

CAO X, Yuan H, Liang J, Huang H, et al
Elective Switching on Biosimilars: Far More Than Nonmedical Switching.
Inflamm Bowel Dis. 2022;28:e101-e102.
PubMed

KAYAL M, Plietz M, Wang YHW, Khaitov S, et al
Crohn's Disease Like Pouch Inflammation Is Associated With Decreased Odds of Secondary Ileostomy Closure After Ileal Pouch Anal Anastomosis.
Inflamm Bowel Dis. 2022;28:1123-1125.
PubMed

BAR N, Avraham Y, Dubinsky V, Cohen NA, et al
Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.
Inflamm Bowel Dis. 2022;28:1027-1033.
PubMed Abstract available

WIJNANDS AM, Te Groen M, Peters Y, Kaptein AA, et al
Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Inflamm Bowel Dis. 2022;28:1053-1060.
PubMed Abstract available

D'HAENS GR, Reinisch W, Lee SD, Tarabar D, et al
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study.
Inflamm Bowel Dis. 2022;28:1034-1044.
PubMed Abstract available

June 2022

CLAXTON BB, Sun G, Nahar R, Henry C, et al
Myocardial Infarction With Nonobstructive Coronary Arteries in New-onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jun 30. pii: 6623438. doi: 10.1093.
PubMed

HARLAN NP, Roberts J, Siegel C, Buckey JC, et al
Hyperbaric Oxygen as Successful Monotherapy for a Severe Ulcerative Colitis Flare.
Inflamm Bowel Dis. 2022 Jun 30. pii: 6623436. doi: 10.1093.
PubMed

EL HAGE CHEHADE N, Ghoneim S, Shah S, Chahine A, et al
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
Inflamm Bowel Dis. 2022 Jun 29. pii: 6619552. doi: 10.1093.
PubMed Abstract available

WELSH S, Sam Z, Seenan JP, Nicholson GA, et al
The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2022 Jun 29. pii: 6619547. doi: 10.1093.
PubMed Abstract available

PREZIOSI NA, Rizvi AH, Feerick JD, Mandelia C, et al
De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters.
Inflamm Bowel Dis. 2022 Jun 28. pii: 6619087. doi: 10.1093.
PubMed

SEDANO R, Hogan M, Zou G, Narula N, et al
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
Inflamm Bowel Dis. 2022 Jun 24. pii: 6617565. doi: 10.1093.
PubMed

INNOCENTI T, Bigagli E, Lynch EN, Galli A, et al
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
Inflamm Bowel Dis. 2022 Jun 24. pii: 6617564. doi: 10.1093.
PubMed Abstract available

ARJOMAND FARD N, Armstrong H, Perry T, Wine E, et al
Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?
Inflamm Bowel Dis. 2022 Jun 24. pii: 6617562. doi: 10.1093.
PubMed Abstract available

LIU E, Laube R, Leong RW, Fraser A, et al
Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making.
Inflamm Bowel Dis. 2022 Jun 17. pii: 6609865. doi: 10.1093.
PubMed Abstract available

JORDAN A, Maraj B, Kinnucan J
Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy.
Inflamm Bowel Dis. 2022 Jun 14. pii: 6608386. doi: 10.1093.
PubMed

LONG MD, Afzali A, Fischer M, Hudesman D, et al
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
Inflamm Bowel Dis. 2022 Jun 14. pii: 6608417. doi: 10.1093.
PubMed Abstract available

KAWAMOTO A, Fujii T, Mitani R, Suzuki Y, et al
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Jun 14. pii: 6608379. doi: 10.1093.
PubMed

STAFFORD IS, Gosink MM, Mossotto E, Ennis S, et al
A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.
Inflamm Bowel Dis. 2022 Jun 14. pii: 6608231. doi: 10.1093.
PubMed Abstract available

TIAN WN, Huang YH, Dai C
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.
Inflamm Bowel Dis. 2022 Jun 6. pii: 6603234. doi: 10.1093.
PubMed

JEDEL S, Beck T, Swanson G, Hood MM, et al
Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial.
Inflamm Bowel Dis. 2022 Jun 4. pii: 6602039. doi: 10.1093.
PubMed Abstract available

TURSI A, Nenna R
COVID-19 as a Trigger for De Novo Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e76-e77.
PubMed

ZHANG Y, Tian F, Li H
Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn's Disease Treated With Infliximab.
Inflamm Bowel Dis. 2022;28:e80-e81.
PubMed

STIDHAM RW, Yu D, Zhao X, Bishu S, et al
Identifying the Presence, Activity, and Status of Extraintestinal Manifestations of Inflammatory Bowel Disease Using Natural Language Processing of Clinical Notes.
Inflamm Bowel Dis. 2022 Jun 3. pii: 6601382. doi: 10.1093.
PubMed Abstract available

YU M, Zhu W, Wang J, Chen X, et al
Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
Inflamm Bowel Dis. 2022;28:923-935.
PubMed Abstract available

WANG B, Li R, Zhang S, Zhao Q, et al
A Case of Behcet's Disease With Hepatic Lesions Misdiagnosed as Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e86-e87.
PubMed

DONG G, Yang Y, Zhang H, Yu W, et al
Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC.
Inflamm Bowel Dis. 2022;28:830-842.
PubMed Abstract available

WANG X, Tang J, Zheng JW, Huang WF, et al
Granulomatous Pneumonia and Liver Lesions Associated With Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e78-e79.
PubMed

SORENSEN KM, Jensen CH, Sheikh SP, Qvist N, et al
Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.
Inflamm Bowel Dis. 2022;28:967-970.
PubMed

FRADKOV E, Sheehan J, Cushing K, Higgins PDR, et al
Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease.
Inflamm Bowel Dis. 2022;28:895-904.
PubMed Abstract available

CHEN G, Pedarla V, Null KD, Cazzetta SE, et al
Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
Inflamm Bowel Dis. 2022;28:870-877.
PubMed Abstract available

JAVAID A, Shahab O, Adorno W, Fernandes P, et al
Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:819-829.
PubMed Abstract available

NOORIAN S, Jeon Y, Nguyen MT, Sauk J, et al
The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
Inflamm Bowel Dis. 2022;28:878-887.
PubMed Abstract available

WITGES K, Sexton K, Graff LA, Targownik LE, et al
What Is a Flare? The Manitoba Living With IBD Study.
Inflamm Bowel Dis. 2022;28:862-869.
PubMed Abstract available

BROMS G
IBD in the Postpartum Period: Spotlight on Maternal Outcomes.
Inflamm Bowel Dis. 2022;28:980-981.
PubMed

ABOUBAKR A, Gottlieb ZS, Riggs AR, Johnson SO, et al
Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD.
Inflamm Bowel Dis. 2022;28:843-849.
PubMed Abstract available

RANGEL PANIZ G, Lebow J, Sim L, Lacy BE, et al
Eating Disorders: Diagnosis and Management Considerations for the IBD Practice.
Inflamm Bowel Dis. 2022;28:936-946.
PubMed

CAO Q, Chen C, Gao X, Chen Y, et al
Real-world Short-term Effectiveness of Ustekinumab in Crohn's Disease: Results from a Multicenter, Prospective Study in China.
Inflamm Bowel Dis. 2022;28.
PubMed

PENG L, Hu S, Yu Q, Chen Y, et al
Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

CHEN YJ, Chen BL, Liang MJ, Chen SL, et al
Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn's Disease: A Pilot Study.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

ARKENBOSCH JHC, Mak JWY, Ho JCL, Beelen EMJ, et al
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

YAO L, Chen H, Shao B, Liu J, et al
Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

BAI X, Zhang H, Ruan G, Lv H, et al
Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn's Disease in China: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

WINTHROP KL, Vermeire S, Long MD, Panes J, et al
Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
Inflamm Bowel Dis. 2022 Jun 1. pii: 6596831. doi: 10.1093.
PubMed Abstract available

May 2022

TSE CS, Melmed GY, Siegel CA, Weng CH, et al
Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study.
Inflamm Bowel Dis. 2022 May 28. pii: 6594471. doi: 10.1093.
PubMed

WINTER RW, Boyd T, Chan WW, Levy AN, et al
Risk Factors for Voluntary Childlessness in Men and Women With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 May 28. pii: 6594473. doi: 10.1093.
PubMed

WU S, Xie S, Yuan C, Yang Z, et al
Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
Inflamm Bowel Dis. 2022 May 27. pii: 6594105. doi: 10.1093.
PubMed Abstract available

SOOKAROMDEE P, Wiwanitkit V
Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2022 May 27. pii: 6594100. doi: 10.1093.
PubMed

GOLD SL, Rabinowitz LG, Manning L, Keefer L, et al
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.
Inflamm Bowel Dis. 2022 May 19. pii: 6589577. doi: 10.1093.
PubMed Abstract available

GOODYEAR BG, Heidari F, Ingram RJM, Cortese F, et al
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 May 19. pii: 6589553. doi: 10.1093.
PubMed Abstract available

SLEUTJES JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC, et al
Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
Inflamm Bowel Dis. 2022 May 19. pii: 6589576. doi: 10.1093.
PubMed Abstract available

KAWASHIMA K, Oshima N, Kishimoto K, Kataoka M, et al
Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
Inflamm Bowel Dis. 2022 May 18. pii: 6588003. doi: 10.1093.
PubMed Abstract available

MADSEN GR, Bertl K, Pandis N, Stavropoulos A, et al
The Impact of Periodontitis on Inflammatory Bowel Disease Activity.
Inflamm Bowel Dis. 2022 May 12. pii: 6584926. doi: 10.1093.
PubMed Abstract available

DE KRIJGER M, Carvalho B, Rausch C, Bolijn AS, et al
Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 May 11. pii: 6584483. doi: 10.1093.
PubMed Abstract available

RIZVI A, Trivedi P, Bar-Mashiah A, Plietz M, et al
Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis.
Inflamm Bowel Dis. 2022 May 11. pii: 6584485. doi: 10.1093.
PubMed

DE SIRE R, Rispo A, Compare D, Tortora F, et al
Wernicke Encephalopathy in Ulcerative Colitis.
Inflamm Bowel Dis. 2022;28:e70-e71.
PubMed

BATTAT R
Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2022;28:e61.
PubMed

MC GETTIGAN N, Boland K, O'Toole A
Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2022;28:e59-e60.
PubMed

PEREZ K, Ngollo M, Rabinowitz K, Hammoudi N, et al
Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
Inflamm Bowel Dis. 2022;28:775-782.
PubMed Abstract available

ETWEBI Z, Goldsmith JR, Bou-Dargham M, Tian Y, et al
TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
Inflamm Bowel Dis. 2022;28:764-774.
PubMed Abstract available

NIGAM GB, Patel RN, Lakhtakia S, Desai D, et al
A Survey of Endoscopists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India.
Inflamm Bowel Dis. 2022;28:e64-e65.
PubMed

GOLUSDA L, Kuhl AA, Siegmund B, Paclik D, et al
Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response.
Inflamm Bowel Dis. 2022;28:801-807.
PubMed Abstract available

ZHAO QF, Wang S
Crohn's Disease Complicated by an Ileo-urachal Fistula.
Inflamm Bowel Dis. 2022;28:e62-e63.
PubMed

HUANG JS, Definis M, Cruz R, Parker J, et al
Patient Portal Usage: An Objective Target for Transition Interventions Among Youth with IBD?
Inflamm Bowel Dis. 2022;28:808-810.
PubMed

ROBLIN X, Genin C, Nancey S, Williet N, et al
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
Inflamm Bowel Dis. 2022;28:720-727.
PubMed Abstract available

GU P, Chhabra A, Chittajallu P, Chang C, et al
Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Inflamm Bowel Dis. 2022;28:657-666.
PubMed Abstract available

BRENNER EJ, Long MD, Mann CM, Lin L, et al
Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity.
Inflamm Bowel Dis. 2022;28:728-733.
PubMed Abstract available

DE CRUZ P, Hamilton AL, Burrell KJ, Gorelik A, et al
Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
Inflamm Bowel Dis. 2022;28:680-688.
PubMed Abstract available

April 2022

LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Apr 30. pii: 6576383. doi: 10.1093.
PubMed

NELSON AD, Elkins JR, Stocchi L, Farraye FA, et al
Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 26. pii: 6574514. doi: 10.1093.
PubMed Abstract available

TORTORA C, Di Paola A, Creoli M, Argenziano M, et al
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 26. pii: 6574513. doi: 10.1093.
PubMed Abstract available

FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
Increased Risk of Postpartum Infections After Caesarian and Vaginal Delivery in Women With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
Inflamm Bowel Dis. 2022 Apr 26. pii: 6574515. doi: 10.1093.
PubMed Abstract available

KWON JY, Daoud ND, Hashash JG, Picco MF, et al
Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 25. pii: 6573907. doi: 10.1093.
PubMed Abstract available

VELOSO FT
Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
Inflamm Bowel Dis. 2022 Apr 23. pii: 6573214. doi: 10.1093.
PubMed

HASAN B, Ur Rahman A
Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub.
Inflamm Bowel Dis. 2022 Apr 23. pii: 6573283. doi: 10.1093.
PubMed

MAO R, Ng SC, Chen M
Network Clinical Collaboration to Improve Quality of Care of Patients with Inflammatory Bowel Disease in China.
Inflamm Bowel Dis. 2022 Apr 20. pii: 6571486. doi: 10.1093.
PubMed

MIKOLAJCZYK AE, Cohen NA, Watson S, Ackerman M, et al
Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Apr 18. pii: 6569959. doi: 10.1093.
PubMed Abstract available

ZIV Y, Swaminath A, Sultan K
Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical.
Inflamm Bowel Dis. 2022 Apr 13. pii: 6568039. doi: 10.1093.
PubMed

LI D, Xu A, Mengesha E, Elyanow R, et al
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
Inflamm Bowel Dis. 2022 Apr 9. pii: 6565880. doi: 10.1093.
PubMed

SEONG G, Song JH, Kim JE, Kim TJ, et al
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
Inflamm Bowel Dis. 2022 Apr 9. pii: 6565877. doi: 10.1093.
PubMed Abstract available

SCHELL TL, Knutson KL, Saha S, Wald A, et al
Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 9. pii: 6565876. doi: 10.1093.
PubMed

MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.
Inflamm Bowel Dis. 2022 Apr 8. pii: 6565439. doi: 10.1093.
PubMed

MUNGMUNPUNTIPANTIP R, Wiwanitkit V
Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence.
Inflamm Bowel Dis. 2022 Apr 8. pii: 6565438. doi: 10.1093.
PubMed

VALENTIN S, Renel B, Manneville F, Caron B, et al
Prevalence of and Factors Associated with Respiratory Symptoms Among Patients with Inflammatory Bowel Disease: A Prospective Study.
Inflamm Bowel Dis. 2022 Apr 8. pii: 6565436. doi: 10.1093.
PubMed Abstract available

MACALUSO FS, Giuliano A, Fries W, Viola A, et al
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Inflamm Bowel Dis. 2022 Apr 6. pii: 6564282. doi: 10.1093.
PubMed Abstract available

KUANG R, O'Keefe SJD, Ramos Del Aguila de Rivers C, Koutroumpakis F, et al
Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 5. pii: 6563753. doi: 10.1093.
PubMed Abstract available

DUBINSKY MC, Magro F, Steinwurz F, Hudesman DP, et al
Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis. 2022 Apr 5. pii: 6563756. doi: 10.1093.
PubMed Abstract available

AGRAWAL M, Petralia F, Tepler A, Durbin L, et al
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials.
Inflamm Bowel Dis. 2022 Apr 2. pii: 6562696. doi: 10.1093.
PubMed Abstract available

BERGAMASCHI G, Castiglione F, D'Inca R, Astegiano M, et al
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
Inflamm Bowel Dis. 2022 Apr 2. pii: 6562695. doi: 10.1093.
PubMed Abstract available

ZHANG W, Scalori A, Fuh F, McBride J, et al
Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
Inflamm Bowel Dis. 2022 Apr 2. pii: 6562694. doi: 10.1093.
PubMed

FAYE AS, Dodson JA, Shaukat A
Sarcopenia as a Risk Prediction Tool in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Apr 2. pii: 6562699. doi: 10.1093.
PubMed

March 2022

COATES MD, Ba DM, Liu G, Dalessio S, et al
Response to the Letter to the Editor: "Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease".
Inflamm Bowel Dis. 2022 Mar 31. pii: 6561784. doi: 10.1093.
PubMed

PATIL SA, Bhat S, Limdi JK, Farraye FA, et al
The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Mar 30. pii: 6556005. doi: 10.1093.
PubMed

MUNGMUNPUNTIPANTIP R, Wiwanitkit V
Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:e45.
PubMed

COSTANTINO A, Noviello D, Costantino C, Vecchi M, et al
Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".
Inflamm Bowel Dis. 2022;28:e57-e58.
PubMed

SCHRODER AL, Chami B, Liu Y, Doyle CM, et al
Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.
Inflamm Bowel Dis. 2022;28:586-598.
PubMed Abstract available

CHANDRASEKHARAN B, Boyer D, Owens JA, Wolfarth AA, et al
Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.
Inflamm Bowel Dis. 2022;28:502-513.
PubMed Abstract available

LIGHTNER AL, Buhulaigah H, Zaghiyan K, Holubar SD, et al
Is Intestinal Diversion an Effective Treatment for Distal Crohn's Disease?
Inflamm Bowel Dis. 2022;28:547-552.
PubMed Abstract available

LAWRENCE LS, Heider A, Singer AAM, Neef HC, et al
Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn's Complications-But May Be Preventable.
Inflamm Bowel Dis. 2022;28:523-530.
PubMed Abstract available

GANDHI S, Zelman S, De Armas RE, Hemond C, et al
Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis.
Inflamm Bowel Dis. 2022 Mar 26. pii: 6554576. doi: 10.1093.
PubMed

DASHARATHY SS, Long MD, Lackner JM, Ben-Ami Shor D, et al
Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Mar 24. pii: 6553867. doi: 10.1093.
PubMed Abstract available

GREYWOODE R, Ullman T, Keefer L
National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Mar 24. pii: 6553591. doi: 10.1093.
PubMed Abstract available

RANA T
Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Mar 21. pii: 6551624. doi: 10.1093.
PubMed Abstract available

PETERSON AR, Srinivasan A, Proud D, Jackett L, et al
Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant.
Inflamm Bowel Dis. 2022 Mar 15. pii: 6548883. doi: 10.1093.
PubMed

CHRISTENSEN B, Prentice RE, Al-Ani AH, Zhang E, et al
Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement.
Inflamm Bowel Dis. 2022 Mar 14. pii: 6548311. doi: 10.1093.
PubMed

NOGUCHI T, Ando T, Emoto S, Nozawa H, et al
Artificial Intelligence Program to Predict p53 Mutations in Ulcerative Colitis-Associated Cancer or Dysplasia.
Inflamm Bowel Dis. 2022 Mar 12. pii: 6547691. doi: 10.1093.
PubMed Abstract available

HAASNOOT ML, Mookhoek A, Duijvestein M, D'Haens GRAM, et al
Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Mar 11. pii: 6547139. doi: 10.1093.
PubMed Abstract available

PETER I, Dubinsky M, Xuan S, Chen N, et al
Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
Inflamm Bowel Dis. 2022 Mar 10. pii: 6546455. doi: 10.1093.
PubMed

SHEN J, Liang J, Mao R, Ran Z, et al
Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center.
Inflamm Bowel Dis. 2022 Mar 5. pii: 6542945. doi: 10.1093.
PubMed Abstract available

OZSOY M, Stummer N, Zimmermann FA, Feichtinger RG, et al
Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Mar 5. pii: 6542923. doi: 10.1093.
PubMed Abstract available

SPIERA E, Ganjian DY, Zhang X, Brenner EJ, et al
Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
Inflamm Bowel Dis. 2022 Mar 3. pii: 6541762. doi: 10.1093.
PubMed

HUDHUD D, Caldera F, Cross RK
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
Inflamm Bowel Dis. 2022;28:492-493.
PubMed

COSTANTINO A, Noviello D, Conforti FS, Aloi M, et al
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.
Inflamm Bowel Dis. 2022;28:474-478.
PubMed

YU B, Lin C, Yang Y, Yang YF, et al
Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.
Inflamm Bowel Dis. 2022;28:e40-e42.
PubMed

RAGHAVA RG, Sharma V, Malegaonkar SK, Dhooria S, et al
Tracheobronchial Crohn's Disease: Case Report and Systematic Review of the Literature.
Inflamm Bowel Dis. 2022;28:e33-e35.
PubMed

SOFIA C, Adiletta V, Iovene B, Sgalla G, et al
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e31-e32.
PubMed

DULANEY D, Dave P, Walsh S, Mehandru S, et al
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature.
Inflamm Bowel Dis. 2022;28:479-483.
PubMed

NICOLETTI F, Hammer L, Furtado S, Mangano K, et al
Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis.
Inflamm Bowel Dis. 2022;28:455-465.
PubMed Abstract available

BISCAGLIA G, Latiano A, Castellana S, Fontana R, et al
Germline Alterations in Patients With IBD-associated Colorectal Cancer.
Inflamm Bowel Dis. 2022;28:447-454.
PubMed Abstract available

MARK-CHRISTENSEN A, Lange A, Erichsen R, Froslev T, et al
Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study.
Inflamm Bowel Dis. 2022;28:415-422.
PubMed Abstract available

BENNETT A, Mamunes A, Kim M, Duley C, et al
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.
Inflamm Bowel Dis. 2022;28:409-414.
PubMed Abstract available

SINGH S, Qian AS, Nguyen NH, Ho SKM, et al
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016.
Inflamm Bowel Dis. 2022;28:364-372.
PubMed Abstract available

WHITE BA, Ramos GP, Kane S
The Impact of Alcohol in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:466-473.
PubMed Abstract available

YADAV A, Jena A, Arpitha K, Shah J, et al
Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease.
Inflamm Bowel Dis. 2022 Mar 1. pii: 6540315. doi: 10.1093.
PubMed

SHEEHAN JL, Jacob J, Berinstein EM, Greene-Higgs L, et al
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2022 Mar 1. pii: 6540317. doi: 10.1093.
PubMed Abstract available

February 2022

MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination.
Inflamm Bowel Dis. 2022 Feb 26. pii: 6537472. doi: 10.1093.
PubMed

LAMERS CR, de Roos NM, Heerink HH, van de Worp-Kalter LA, et al
Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention.
Inflamm Bowel Dis. 2022 Feb 25. pii: 6536898. doi: 10.1093.
PubMed Abstract available

GROSEN A, Bellaguarda E, Liljeqvist-Soltic I, Mejlby Hansen M, et al
Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
Inflamm Bowel Dis. 2022 Feb 25. pii: 6536901. doi: 10.1093.
PubMed

QUERA R, Nunez F P, Flores L
SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Feb 22. pii: 6534444. doi: 10.1093.
PubMed

VALDES DELGADO T, Barranco Castro D, Arguelles Arias F
Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Feb 22. pii: 6534443. doi: 10.1093.
PubMed

PHILIPPOU A, Birhanu B, Biello A, Keefer L, et al
A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Feb 22. pii: 6534445. doi: 10.1093.
PubMed Abstract available

KAYAL M, Kohler D, Plietz M, Khaitov S, et al
Early Pouchitis Is Associated With Crohn's Disease-like Pouch Inflammation in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Feb 21. pii: 6533541. doi: 10.1093.
PubMed Abstract available

CAMPBELL JP, Teigen L, Manski S, Blumhof B, et al
Sarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients.
Inflamm Bowel Dis. 2022 Feb 15. pii: 6528831. doi: 10.1093.
PubMed Abstract available

BOYD T, Winter RW, Winter HS, Kissous-Hunt M, et al
Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Feb 15. pii: 6528828. doi: 10.1093.
PubMed

BERBISA MAF, Nielsen KR, Ingham AC, Midjord J, et al
Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
Inflamm Bowel Dis. 2022 Feb 9. pii: 6524838. doi: 10.1093.
PubMed Abstract available

XIE Y, Li H, Zhou L, Tian F, et al
A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Feb 4. pii: 6522051. doi: 10.1093.
PubMed

CHONGSRISAWAT V, Suratannon N, Chatchatee P, Ittiwut R, et al
Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.
Inflamm Bowel Dis. 2022 Feb 4. pii: 6522222. doi: 10.1093.
PubMed

THOMAS PWA, den Broeder N, Derikx M, Kievit W, et al
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
Inflamm Bowel Dis. 2022 Feb 4. pii: 6522042. doi: 10.1093.
PubMed Abstract available

BOKEMEYER B, Picker N, Wilke T, Rosin L, et al
Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data.
Inflamm Bowel Dis. 2022 Feb 4. pii: 6522041. doi: 10.1093.
PubMed Abstract available

MOGHADAM P, Dumas M, Blum L, Gimenez I, et al
Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn's Disease Under Anti-TNF Therapy.
Inflamm Bowel Dis. 2022;28:e25-e26.
PubMed

JOHNSON S, Ko J, Halabi WJ, Stondell J, et al
Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e17.
PubMed

UENO A, Jijon HB, Peng R, Sparksman S, et al
Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease.
Inflamm Bowel Dis. 2022;28:246-258.
PubMed Abstract available

LEE SD, Singla A, Harper J, Barahimi M, et al
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
Inflamm Bowel Dis. 2022;28:309-313.
PubMed Abstract available

WIEGHARD NEK
The Difficulty of Distal Crohn's Disease and the Utility of Diverting Stomas.
Inflamm Bowel Dis. 2022;28:325-326.
PubMed

ALRIC H, Amiot A, Kirchgesner J, Treton X, et al
Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease.
Inflamm Bowel Dis. 2022;28:218-225.
PubMed Abstract available

ADLER J, Lee GJ, Singer AAM
Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working.
Inflamm Bowel Dis. 2022;28:322-324.
PubMed

LIEFFERINCKX C, Bottieau J, Toubeau JF, Thomas D, et al
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2022;28:208-217.
PubMed Abstract available

January 2022

TANDON P, Lee E, Jogendran R, Kroeker KI, et al
Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study.
Inflamm Bowel Dis. 2022 Jan 31. pii: 6517873. doi: 10.1093.
PubMed Abstract available

GUZZO GL, Andrews JM, Weyrich LS
The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jan 29. pii: 6517341. doi: 10.1093.
PubMed Abstract available

HE ZX, Wang SL, Zhao SB, Li ZS, et al
An Unusual Case of Hypernatremia in Patient With Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Jan 29. pii: 6517203. doi: 10.1093.
PubMed

DA LUZ MOREIRA A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, et al
Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study.
Inflamm Bowel Dis. 2022 Jan 28. pii: 6516702. doi: 10.1093.
PubMed Abstract available

TARABAR D, El Jurdi K, Traboulsi C, Yvellez O, et al
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Inflamm Bowel Dis. 2022 Jan 25. pii: 6515101. doi: 10.1093.
PubMed Abstract available

SEDANO R, Hogan M, McDonald C, Aswani-Omprakash T, et al
Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials.
Inflamm Bowel Dis. 2022 Jan 25. pii: 6515239. doi: 10.1093.
PubMed

LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.
Inflamm Bowel Dis. 2022;28.
PubMed Abstract available

PETERSON AR, Hilley P, De Cruz P
Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary?
Inflamm Bowel Dis. 2022 Jan 19. pii: 6511711. doi: 10.1093.
PubMed

COWHERD E, Egberg MD, Kappelman MD, Zhang X, et al
The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Jan 18. pii: 6510907. doi: 10.1093.
PubMed Abstract available

RUNDE J, Erondu A, Akiyama S, Traboulsi C, et al
Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Jan 18. pii: 6510906. doi: 10.1093.
PubMed Abstract available

MASSIMINO L, Spano S, Lamparelli LA, Fuggetta D, et al
Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients.
Inflamm Bowel Dis. 2022 Jan 15. pii: 6507842. doi: 10.1093.
PubMed

KAPLAN GG, Underwood FE, Coward S, Agrawal M, et al
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.
Inflamm Bowel Dis. 2022 Jan 15. pii: 6507839. doi: 10.1093.
PubMed Abstract available

LEWIS JD, Cross RK, Long M, Singh S, et al
High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jan 11. pii: 6503739. doi: 10.1093.
PubMed

KIM SC
Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2022 Jan 11. pii: 6503738. doi: 10.1093.
PubMed

CUSHING KC, Du X, Chen Y, Stetson LC, et al
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer.
Inflamm Bowel Dis. 2022 Jan 8. pii: 6501204. doi: 10.1093.
PubMed Abstract available

PARK J, Kang SJ, Yoon H, Park J, et al
Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
Inflamm Bowel Dis. 2022 Jan 7. pii: 6500768. doi: 10.1093.
PubMed Abstract available

PRENTICE R, Wright EK, Flanagan E, Ross AL, et al
The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.
Inflamm Bowel Dis. 2022;28:e13-e16.
PubMed

WEI Y, Yang W, Mei Q
Detection of a Novel Antigen for Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e5-e6.
PubMed

WEN HZ, He ZH, Li PH, Zhao QF, et al
Gluteal Sinus Presenting as the Initial Symptom in a Patient With Crohn's Disease.
Inflamm Bowel Dis. 2022;28:e11-e12.
PubMed

NAZARI H, Naei VY, Tabasi AH, Badripour A, et al
Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease.
Inflamm Bowel Dis. 2022;28:133-142.
PubMed Abstract available

DALAL RS, Gupta S, Goodrick H, Mitri J, et al
Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.
Inflamm Bowel Dis. 2022;28:146-149.
PubMed

BOUCHER G, Paradis A, Chabot-Roy G, Coderre L, et al
Serum Analyte Profiles Associated With Crohn's Disease and Disease Location.
Inflamm Bowel Dis. 2022;28:9-20.
PubMed Abstract available

FAYE AS, Colombel JF
Aging and IBD: A New Challenge for Clinicians and Researchers.
Inflamm Bowel Dis. 2022;28:126-132.
PubMed Abstract available

JOUSTRA V, Duijvestein M, Mookhoek A, Bemelman W, et al
Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.
Inflamm Bowel Dis. 2022;28:1-8.
PubMed Abstract available

TAPETE G, Bertani L, Pieraccini A, Lynch EN, et al
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
Inflamm Bowel Dis. 2022;28:62-69.
PubMed Abstract available

BERMEJO F, Jimenez L, Algaba A, Vela M, et al
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Inflamm Bowel Dis. 2022;28:41-47.
PubMed Abstract available

LIU J, Ge X, Ouyang C, Wang D, et al
Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jan 4. pii: 6497520. doi: 10.1093.
PubMed Abstract available

YANG H, Qian J
Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: A questionnaire-based multi-center study.
Inflamm Bowel Dis. 2022 Jan 4. pii: 6497521. doi: 10.1093.
PubMed Abstract available

ASHTON JJ, Boukas K, Stafford IS, Cheng G, et al
Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2022 Jan 3. pii: 6492639. doi: 10.1093.
PubMed Abstract available

LARSEN MD, Norgard BM, Kjeldsen J
Does Disease Activity After Induction Treatment With Biologics Predict Short-Term Outcome in Crohn's Disease and Ulcerative Colitis?
Inflamm Bowel Dis. 2022 Jan 3. pii: 6491898. doi: 10.1093.
PubMed Abstract available

December 2021

FANG L, Gao H, Gao X, Wu W, et al
Risks of Cardiovascular Events in Patients with Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
Inflamm Bowel Dis. 2021 Dec 30. pii: 6490203. doi: 10.1093.
PubMed Abstract available

DULAI PS, Wong ECL, Reinisch W, Colombel JF, et al
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab.
Inflamm Bowel Dis. 2021 Dec 30. pii: 6490022. doi: 10.1093.
PubMed Abstract available

MEISINGER C, Freuer D
Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Inflamm Bowel Dis. 2021 Dec 29. pii: 6488545. doi: 10.1093.
PubMed Abstract available

SANDBORN WJ, Armuzzi A, Liguori G, Irving PM, et al
Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Dec 27. pii: 6484790. doi: 10.1093.
PubMed Abstract available

SHAH R, Elangovan A, Jordan DW, Katz J, et al
10-Year Trend of Abdominal Magnetic Resonance Imaging Compared With Abdominal Computed Tomography Scans in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Dec 22. pii: 6479634. doi: 10.1093.
PubMed Abstract available

SINGH AK, Sasani A, Dhamor D, Jena A, et al
Surgical Management of Medical Refractory Acute Severe Ulcerative Colitis in Immune Thrombocytopenic Purpura: Killing Two Birds With One Stone.
Inflamm Bowel Dis. 2021 Dec 20. pii: 6470737. doi: 10.1093.
PubMed

ELIA JR, Beck KR
The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to "Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review".
Inflamm Bowel Dis. 2021 Dec 18. pii: 6469656. doi: 10.1093.
PubMed

SHIMODAIRA Y, Watanabe K, Takahashi S, Koizumi S, et al
Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2.
Inflamm Bowel Dis. 2021 Dec 18. pii: 6469651. doi: 10.1093.
PubMed

HILL JE, Pena-Sanchez JN, Fernando C, Freitas AC, et al
Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Dec 17. pii: 6468817. doi: 10.1093.
PubMed Abstract available

RAMAN M, Reimer RA, Ghosh S, Vallance J, et al
The Importance of Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
Inflamm Bowel Dis. 2021 Dec 17. pii: 6468793. doi: 10.1093.
PubMed

BAMIAS G, Pizarro TT, Cominelli F
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Dec 14. pii: 6460699. doi: 10.1093.
PubMed Abstract available

YANG L, Song X, Chen Y, Li Y, et al
Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2021 Dec 11. pii: 6459488. doi: 10.1093.
PubMed Abstract available

TSE CS, Siegel CA, Weaver SA, Oliver BJ, et al
Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study.
Inflamm Bowel Dis. 2021 Dec 10. pii: 6459204. doi: 10.1093.
PubMed Abstract available

JENA A, Sachan A, Singh AK, Sharma V, et al
Multifocal Pyoderma Gangrenosum at Presentation in a Patient With Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Dec 10. pii: 6459194. doi: 10.1093.
PubMed

WAN Y, Yang L, Jiang S, Qian D, et al
Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis.
Inflamm Bowel Dis. 2021 Dec 6. pii: 6454294. doi: 10.1093.
PubMed Abstract available

WEAVER KN, Zhang X, Dai X, Watkins R, et al
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Inflamm Bowel Dis. 2021 Dec 6. pii: 6454297. doi: 10.1093.
PubMed Abstract available

November 2021

LEITE-GOMES E, Dias AM, Azevedo CM, Santos-Pereira B, et al
Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.
Inflamm Bowel Dis. 2021 Nov 29. pii: 6446097. doi: 10.1093.
PubMed Abstract available

SUN Y, Geng J, Chen X, Chen H, et al
Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
Inflamm Bowel Dis. 2021 Nov 29. pii: 6445975. doi: 10.1093.
PubMed Abstract available

CERNA K, Duricova D, Lukas M, Machkova N, et al
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
Inflamm Bowel Dis. 2021 Nov 29. pii: 6445976. doi: 10.1093.
PubMed Abstract available

ZHANG W, Scalori A, Fuh F, McBride J, et al
Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
Inflamm Bowel Dis. 2021 Nov 29. pii: 6446094. doi: 10.1093.
PubMed Abstract available

BIRDA CL, Agarwal A, Goyal A
A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Nov 24. pii: 6438178. doi: 10.1093.
PubMed

DESALERMOS A, Pimienta M, Kalligeros M, Shehadeh F, et al
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2021 Nov 24. pii: 6438176. doi: 10.1093.
PubMed Abstract available

KJELDSEN S, Nielsen J, Mertz Norgard B, Kjeldsen J, et al
Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
Inflamm Bowel Dis. 2021 Nov 24. pii: 6438420. doi: 10.1093.
PubMed Abstract available

WESTBERG K, Olen O, Soderling J, Bengtsson J, et al
Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.
Inflamm Bowel Dis. 2021 Nov 18. pii: 6430979. doi: 10.1093.
PubMed Abstract available

SACHAN A, Singh AK
Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.
Inflamm Bowel Dis. 2021 Nov 15. pii: 6428578. doi: 10.1093.
PubMed

PAPALIA I, Tjandra D, Quah S, Tan C, et al
Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

LI Y, Chen J, Bolinger AA, Chen H, et al
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

HONIG G, Larkin PB, Heller C, Hurtado-Lorenzo A, et al
Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

MOTTA JP, Deraison C, Le Grand S, Le Grand B, et al
PAR-1 Antagonism to Promote Gut Mucosa Healing in Crohn's Disease Patients: A New Avenue for CVT120165.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

YAU YY, Wasinger VC, Hirten RP, Chuang E, et al
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

BUSQUETS D, Oliver L, Amoedo J, Ramio-Pujol S, et al
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
Inflamm Bowel Dis. 2021;27.
PubMed Abstract available

TANG J, Huang Z, Guo H, Chao K, et al
Unexpected Liver Lesions in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e161-e162.
PubMed

BORGHINI R, Villanacci V, Oberti A, Caronna R, et al
Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
Inflamm Bowel Dis. 2021;27:e152-e153.
PubMed

DAR ANTAKI L, Volkov A, Ben-Horin S
Cytomegalovirus Limited to the Rectum in an Immunosuppressed IBD Patient.
Inflamm Bowel Dis. 2021;27:e154-e155.
PubMed

ALLEGRETTI JR, Canakis A, McClure E, Marcus J, et al
Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
Inflamm Bowel Dis. 2021;27:2031-2033.
PubMed

AGUILAR D, Revilla L, Garrido-Trigo A, Panes J, et al
Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study.
Inflamm Bowel Dis. 2021;27:1999-2009.
PubMed Abstract available

GHAFARI-SARAVI A, Rabizadeh S, Dubovsky A, Miller S, et al
Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:2034-2037.
PubMed

SOMINENI HK, Weitzner JH, Venkateswaran S, Dodd A, et al
Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:1889-1900.
PubMed Abstract available

MANZINI R, Schwarzfischer M, Atrott K, Laimbacher A, et al
Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
Inflamm Bowel Dis. 2021;27:1986-1998.
PubMed Abstract available

WANG MH, Friton JJ, Raffals LE, Leighton JA, et al
Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.
Inflamm Bowel Dis. 2021;27:1968-1974.
PubMed Abstract available

FLANAGAN E, Wright EK, Sparrow MP, Moore GT, et al
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.
Inflamm Bowel Dis. 2021;27:1909-1918.
PubMed Abstract available

KIM J, Yoon H, Kim N, Lee KM, et al
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
Inflamm Bowel Dis. 2021;27:1931-1941.
PubMed Abstract available

TRIPODI A, Spina L, Pisani LF, Padovan L, et al
Anti-TNF-alpha Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:1901-1908.
PubMed Abstract available

HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
Inflamm Bowel Dis. 2021 Nov 12. pii: 6426108. doi: 10.1093.
PubMed

HOKAMA A, Fujita J
Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?"
Inflamm Bowel Dis. 2021 Nov 12. pii: 6426022. doi: 10.1093.
PubMed

LUTZ MK, Matthews LA, Tuan WJ, Caldera F, et al
Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.
Inflamm Bowel Dis. 2021 Nov 10. pii: 6425060. doi: 10.1093.
PubMed

JAGT JZ, Struys EA, Ayada I, Bakkali A, et al
Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
Inflamm Bowel Dis. 2021 Nov 10. pii: 6425057. doi: 10.1093.
PubMed Abstract available

JENA A, Singh AK, Siddharda BV, Panda P, et al
Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Nov 9. pii: 6425058. doi: 10.1093.
PubMed

ZHANG S, Chen F, Wu J, Liu C, et al
Regional Gray Matter Volume Changes in Brains of Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Nov 3. pii: 6420319. doi: 10.1093.
PubMed Abstract available

October 2021

TRIPATHI K, Godoy Brewer G, Thu Nguyen M, Singh Y, et al
COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2021 Oct 27. pii: 6412576. doi: 10.1093.
PubMed Abstract available

DAI C, Huang YH, Jiang M
Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab.
Inflamm Bowel Dis. 2021 Oct 27. pii: 6412248. doi: 10.1093.
PubMed

KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021;27:1731-1739.
PubMed Abstract available

SPENCER EA, Klang E, Dolinger M, Pittman N, et al
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
Inflamm Bowel Dis. 2021;27:1862-1864.
PubMed

CRISPINO F, Brinch D, Carrozza L, Cappello M, et al
Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
Inflamm Bowel Dis. 2021;27:e134-e135.
PubMed

DALAL RS, Allegretti JR
Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
Inflamm Bowel Dis. 2021;27:1873-1875.
PubMed

CEBALLOS D
Predictors: How to Approach the Individualization of Treatment.
Inflamm Bowel Dis. 2021;27:1876-1877.
PubMed Abstract available

ARTHUR S, Palaniappan B, Afroz S, Sundaram U, et al
Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.
Inflamm Bowel Dis. 2021;27:1804-1812.
PubMed Abstract available

KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial.
Inflamm Bowel Dis. 2021;27:1766-1772.
PubMed Abstract available

STULMAN MY, Asayag N, Focht G, Brufman I, et al
Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study.
Inflamm Bowel Dis. 2021;27:1784-1794.
PubMed Abstract available

CALDERA F, Balzora S, Hayney MS, Farraye FA, et al
Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
Inflamm Bowel Dis. 2021;27:1703-1705.
PubMed Abstract available

KANG MJ, Kim HW, Park SB, Kang DH, et al
A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothpick Mimicking Small Bowel Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e121-e122.
PubMed

VALDES DELGADO T, Arguelles Arias F, Gastearena Idoate MA
Mixed Adenocarcinoma in a 44-Year-Old Male with Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e119-e120.
PubMed

PATEL BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al
Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e124.
PubMed

LOU Y, Li Z
Is It Crohn's Disease?
Inflamm Bowel Dis. 2021;27:e116-e117.
PubMed

ALAYO QA, Khatiwada A, Patel A, Zulfiqar M, et al
Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:1698-1702.
PubMed

ADLER J, Eder SJ, Gebremariam A, French KR, et al
Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CD.
Inflamm Bowel Dis. 2021;27:1585-1592.
PubMed Abstract available

SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:1626-1633.
PubMed Abstract available

KULKARNI C, Murag S, Cholankeril G, Fardeen T, et al
Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
Inflamm Bowel Dis. 2021;27:1602-1609.
PubMed Abstract available

PATEL DB, van Deen WK, Almario CV, Khalil C, et al
Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom.
Inflamm Bowel Dis. 2021;27:1593-1601.
PubMed Abstract available

PIPPIS EJ, Yacyshyn BR
Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD.
Inflamm Bowel Dis. 2021;27:1674-1683.
PubMed Abstract available

REENAERS C, de Roover A, Kohnen L, Nachury M, et al
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
PubMed Abstract available

ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
PubMed Abstract available

YU N, Basnayake C, Connell W, Ding NS, et al
Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
PubMed Abstract available

HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.
PubMed

RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
PubMed Abstract available

September 2021

LEE KE, Lim F, Colombel JF, Hur C, et al
Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 30. pii: 6378418. doi: 10.1093.
PubMed Abstract available

GU X, Ke X, Shen M, Zhang M, et al
Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study.
Inflamm Bowel Dis. 2021 Sep 30. pii: 6378417. doi: 10.1093.
PubMed

MICHEL HK, Boyle B, David J, Donegan A, et al
The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.
Inflamm Bowel Dis. 2021 Sep 25. pii: 6375326. doi: 10.1093.
PubMed Abstract available

BOOTH A, Ford W, Brennan E, Magwood G, et al
Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 23. pii: 6374390. doi: 10.1093.
PubMed Abstract available

MACISAAC MB, Julsgaard M, Flanagan E, Rowe S, et al
Anti-TNFalpha Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
Inflamm Bowel Dis. 2021 Sep 18. pii: 6372251. doi: 10.1093.
PubMed

LAWTON RC
"The Tough Get Going": Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 17. pii: 6371841. doi: 10.1093.
PubMed

DAILEY J, Kozhaya L, Dogan M, Hopkins D, et al
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 16. pii: 6371006. doi: 10.1093.
PubMed Abstract available

OUAHED J
Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 15. pii: 6370827. doi: 10.1093.
PubMed Abstract available

BADER-MEUNIER B, Martins AL, Charbit-Henrion F, Meinzer U, et al
Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 15. pii: 6370829. doi: 10.1093.
PubMed Abstract available

VAHIDNEZHAD H, Youssefian L, Anbardar MH, Zeinali S, et al
Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the alpha6 Integrin Gene (ITGA6).
Inflamm Bowel Dis. 2021 Sep 15. pii: 6370826. doi: 10.1093.
PubMed

MISHRA S, Kumar Singh A, Kopp C, Jena A, et al
Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib.
Inflamm Bowel Dis. 2021 Sep 15. pii: 6370835. doi: 10.1093.
PubMed

DE VOOGD F, Joshi H, Van Wassenaer E, Bots S, et al
Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Sep 15. pii: 6370832. doi: 10.1093.
PubMed Abstract available

WU N, Li H, Zhang J, Huang W, et al
Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?
Inflamm Bowel Dis. 2021 Sep 4. pii: 6364140. doi: 10.1093.
PubMed

HERMAN SM, Zaborniak K, Bernstein CN
Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
Inflamm Bowel Dis. 2021 Sep 2. pii: 6362805. doi: 10.1093.
PubMed Abstract available

BARNES EL, Nowell WB, Venkatachalam S, Dobes A, et al
Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
Inflamm Bowel Dis. 2021 Sep 2. pii: 6362806. doi: 10.1093.
PubMed Abstract available

August 2021

PHILIPPOU A, Sehgal P, Ungaro RC, Wang K, et al
High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Aug 27. pii: 6358608. doi: 10.1093.
PubMed Abstract available

XERFAN EMS, Andersen ML, Tomimori J, Tufik S, et al
Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues.
Inflamm Bowel Dis. 2021 Aug 27. pii: 6358561. doi: 10.1093.
PubMed

RAFFALS LE, Saha S, Bewtra M, Norris C, et al
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
Inflamm Bowel Dis. 2021 Aug 26. pii: 6358125. doi: 10.1093.
PubMed Abstract available

MATSUNE Y, Yaguchi K, Saito S, Sakakibara H, et al
Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum.
Inflamm Bowel Dis. 2021 Aug 26. pii: 6358126. doi: 10.1093.
PubMed

HASSAN-ZAHRAEE M, Ye Z, Xi L, Baniecki ML, et al
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Aug 24. pii: 6357022. doi: 10.1093.
PubMed Abstract available

MALHI G, Tandon P, Perlmutter JW, Nguyen G, et al
Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2021 Aug 24. pii: 6357024. doi: 10.1093.
PubMed Abstract available

XU Y, Tian Y, Li F, Wang Y, et al
Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis.
Inflamm Bowel Dis. 2021 Aug 24. pii: 6357021. doi: 10.1093.
PubMed Abstract available

SABERZADEH-ARDESTANI B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, et al
Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
Inflamm Bowel Dis. 2021 Aug 21. pii: 6356100. doi: 10.1093.
PubMed Abstract available

BARNHOORN MC, Storm BN, de Boer NK, van der Voorn MMPJA, et al
Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
Inflamm Bowel Dis. 2021;27:e114-e115.
PubMed

KOCHAR B, Kalasapudi L, Ufere NN, Nipp RD, et al
Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:1541-1543.
PubMed

WITTE M, Reiner J, Bannert K, Jaster R, et al
Ileocolonic Healing After Extended Small Bowel Resection in Mice: NOD2 Deficiency Impairs Anastomotic Healing and Postoperative Outcome.
Inflamm Bowel Dis. 2021;27:1503-1512.
PubMed Abstract available

GEISMAN T, Chen L, Gray-Swain MR, Hiatt-Jensen D, et al
Delivery Outcomes of Pregnant Patients With Inflammatory Bowel Diseases Compared With the General Population and With Women With Other Autoimmune Diseases at a Tertiary Care Center.
Inflamm Bowel Dis. 2021;27:1418-1426.
PubMed Abstract available

YANG Q, Chen L, Feng L, Liu C, et al
Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Aug 16. pii: 6352953. doi: 10.1093.
PubMed Abstract available

DEL SORDO R, Lupinacci G, Tanzi G, Bassotti G, et al
Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
Inflamm Bowel Dis. 2021 Aug 10. pii: 6347487. doi: 10.1093.
PubMed

July 2021

UNGARO RC, Agrawal M, Brenner EJ, Zhang X, et al
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry.
Inflamm Bowel Dis. 2021 Jul 28. pii: 6329562. doi: 10.1093.
PubMed

FALSEY A, Jo D, Sirak H, Moya D, et al
Corticosteroids Can Be Used to Decrease Antidrug Antibodies in Pediatric Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jul 28. pii: 6329558. doi: 10.1093.
PubMed

AXELRAD JE, Faye A, Slaughter JC, Harpaz N, et al
Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Inflamm Bowel Dis. 2021 Jul 28. pii: 6329560. doi: 10.1093.
PubMed Abstract available

MARKOVIC S, Ivanovski TK, Zogovic B, Kalaba A, et al
The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.
Inflamm Bowel Dis. 2021;27:e90.
PubMed

WINTER MW, Levy LC
Maybe Age Isn't Just a Number: Elderly-onset IBD Is a Demographic Deserving of Specific Considerations.
Inflamm Bowel Dis. 2021;27:1363-1364.
PubMed

PRIVITERA G, Pugliese D, Armuzzi A, Guidi L, et al
Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location.
Inflamm Bowel Dis. 2021;27:e93-e94.
PubMed

NEYAZI M, Bharadwaj SS, Bullers S, Varenyiova Z, et al
Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.
Inflamm Bowel Dis. 2021;27:1316-1327.
PubMed Abstract available

SANTORU ML, Piras C, Murgia F, Leoni VP, et al
Metabolic Alteration in Plasma and Biopsies From Patients With IBD.
Inflamm Bowel Dis. 2021;27:1335-1345.
PubMed Abstract available

MARRIE RA, Graff LA, Fisk JD, Patten SB, et al
The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.
Inflamm Bowel Dis. 2021;27:1285-1293.
PubMed Abstract available

ROZICH JJ, Luo J, Dulai PS, Collins AE, et al
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.
Inflamm Bowel Dis. 2021;27:1215-1223.
PubMed Abstract available

DALAL RS, Njie C, Marcus J, Gupta S, et al
Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.
Inflamm Bowel Dis. 2021;27:1294-1301.
PubMed Abstract available

CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
PubMed

SYAL G, Serrano M, Jain A, Cohen BL, et al
Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
PubMed Abstract available

DAI C, Jiang M, Huang YH
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
PubMed

COATES MD, Ba DM, Liu G, Dalessio S, et al
Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
PubMed Abstract available

SHIBUYA T, Nomura O, Nagahara A
Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
PubMed

OJO BA, VanDussen KL, Rosen MJ
The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
PubMed Abstract available

WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
PubMed Abstract available

KHAN N, Pernes T, Weiss A, Trivedi C, et al
Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
PubMed Abstract available

TSE CS, Singh S, Sandborn WJ
A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
PubMed Abstract available

June 2021

WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
PubMed

CHOSHEN S, Turner D, Pratt LT, Precel R, et al
Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
PubMed Abstract available

TAFT TH, Quinton S, Jedel S, Simons M, et al
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
PubMed Abstract available

HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
PubMed Abstract available

MUTLU EA
IBD Development After Diverticulitis May Hold Clues to IBD Pathogenesis.
Inflamm Bowel Dis. 2021;27:1172-1173.
PubMed

KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
Inflamm Bowel Dis. 2021;27:e79-e80.
PubMed

ALKAISSI LY, Winberg ME, Heil SDS, Haapaniemi S, et al
Antagonism of Adherent Invasive E. coli LF82 With Human alpha-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.
Inflamm Bowel Dis. 2021;27:1116-1127.
PubMed Abstract available

ZHOU LY, Lin SN, Rieder F, Chen MH, et al
Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.
Inflamm Bowel Dis. 2021;27:971-982.
PubMed Abstract available

MAZZURANA L, Bonfiglio F, Forkel M, D'Amato M, et al
Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells.
Inflamm Bowel Dis. 2021;27:1128-1138.
PubMed Abstract available

BUISSON A, Mak WY, Andersen MJ, Lei D, et al
Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
Inflamm Bowel Dis. 2021;27:1008-1016.
PubMed Abstract available

NGUYEN NH, Khera R, Dulai PS, Boland BS, et al
National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.
Inflamm Bowel Dis. 2021;27:1068-1078.
PubMed Abstract available

RINAWI F, Ricciuto A, Church PC, Frost K, et al
Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease.
Inflamm Bowel Dis. 2021;27:1079-1087.
PubMed Abstract available

COLMAN RJ, Tsai YT, Jackson K, Boyle BM, et al
Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:1045-1051.
PubMed Abstract available

HASAN B, Yim Y, Ur Rashid M, Khalid RA, et al
Hyperbaric Oxygen Therapy in Chronic Inflammatory Conditions of the Pouch.
Inflamm Bowel Dis. 2021;27:965-970.
PubMed Abstract available

NGUYEN NH, Luo J, Ohno-Machado L, Sandborn WJ, et al
Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort.
Inflamm Bowel Dis. 2021;27:1026-1034.
PubMed Abstract available

KUROWSKI JA, Milinovich A, Ji X, Bauman J, et al
Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort.
Inflamm Bowel Dis. 2021;27:1035-1044.
PubMed Abstract available

QIN X
High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
PubMed

GALIPEAU HJ, Caminero A, Verdu EF
Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
PubMed

LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
PubMed

GONG L, Xiao J, Yi J, Xiao J, et al
Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
PubMed Abstract available

VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
PubMed Abstract available

DAVID JG, Chute D, Reed B, Saeed S, et al
Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
PubMed

JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
PubMed Abstract available

DANESE S, Peyrin-Biroulet L
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
PubMed Abstract available

MIKAIL M, Wilson A
Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
PubMed

May 2021

LUI J, Ramos GP, Codipilly DC, Katzka D, et al
The Use of Biologics for the Treatment of Esophageal Crohn Disease.
Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
PubMed

LI H, Shu H, Tian F
Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
PubMed

GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
PubMed Abstract available

LIU JJ
Disparity in the Care of black Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
PubMed

SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
PubMed Abstract available

PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
PubMed Abstract available

MORRIS GA, McNicol M, Boyle B, Donegan A, et al
Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
PubMed Abstract available

OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
PubMed Abstract available

IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
PubMed Abstract available

SACHAN A, Srivastava S, Shah J, Singh AK, et al
Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
PubMed

HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
PubMed

HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
PubMed Abstract available

VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
PubMed Abstract available

MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
PubMed Abstract available

CHEAH M, Wilson A, Solh Z, Khanna R, et al
IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
PubMed

VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
PubMed

DOS SANTOS CHM, Koga GA
Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
PubMed

GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
PubMed

SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
PubMed

DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
PubMed Abstract available

HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
PubMed

FASOULAS K, Stergiou E, Soufleris K
Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
PubMed

SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
PubMed

Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
PubMed

TAXONERA C, Alba C, Olivares D, Martin M, et al
Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
Inflamm Bowel Dis. 2021;27:864-869.
PubMed Abstract available

GRAZIANO F, Buse M, Cassata N, Citrano M, et al
Cerebral Venous Thrombosis in a Child With Very-Early-Onset IBD.
Inflamm Bowel Dis. 2021;27:e71-e73.
PubMed

SRINIVASAN A, van Langenberg D, De Cruz P
Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e69.
PubMed

AHMED W, Lukin DJ
Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
Inflamm Bowel Dis. 2021;27:787-790.
PubMed

FIOCCHI C, Iliopoulos D
IBD Systems Biology Is Here to Stay.
Inflamm Bowel Dis. 2021;27:760-770.
PubMed Abstract available

KUROWSKI JA, Bewtra M, Kodish E, Lashner B, et al
Reducing the Spread of Internet Misinformation in IBD: Ethics and Responsibility.
Inflamm Bowel Dis. 2021;27:960-962.
PubMed

SUDHAKAR P, Verstockt B, Cremer J, Verstockt S, et al
Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
Inflamm Bowel Dis. 2021;27:870-886.
PubMed Abstract available

GUPTA N, Lustig RH, Andrews H, Gokhale R, et al
Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study).
Inflamm Bowel Dis. 2021;27:751-759.
PubMed Abstract available

WONG ECL, Marshall JK, Reinisch W, Narula N, et al
Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial.
Inflamm Bowel Dis. 2021;27:848-854.
PubMed Abstract available

LEVINE I, Malik F, Castillo G, Jaros B, et al
Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.
Inflamm Bowel Dis. 2021;27:809-815.
PubMed Abstract available

VARBOBITIS I, Kokkotis G, Gizis M, Perlepe N, et al
The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission.
Inflamm Bowel Dis. 2021;27:826-835.
PubMed Abstract available

ATTAUABI M, Zhao M, Bendtsen F, Burisch J, et al
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:927-939.
PubMed Abstract available

TAXONERA C, Olivares D, Alba C
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
PubMed

JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
PubMed

HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
PubMed Abstract available

DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
PubMed

CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
PubMed Abstract available

JENA A, Mishra S, Sachan A, Singh H, et al
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
PubMed

MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
PubMed Abstract available

ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
PubMed Abstract available

April 2021

XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
PubMed

HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
PubMed Abstract available

RODRIGUEZ-LAGO I, Barreiro-de Acosta M
Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
PubMed

Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
PubMed

ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
Inflamm Bowel Dis. 2021;27:e66.
PubMed

FOTEINOGIANNOPOULOU K, Mala A, Koutroubakis IE
Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case Report.
Inflamm Bowel Dis. 2021;27:e55-e56.
PubMed

MAGEN-RIMON R, Garah J, Rosen I, Shaoul R, et al
Postsurgical Treatment in Pediatric Patients With Crohn's Disease: Physician Practice.
Inflamm Bowel Dis. 2021;27:e51-e54.
PubMed

OSTERMAN MT, VanDussen KL, Gordon IO, Davis EM, et al
Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:677-685.
PubMed Abstract available

PAULIDES E, Boukema I, van der Woude CJ, de Boer NKH, et al
The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review.
Inflamm Bowel Dis. 2021;27:711-724.
PubMed Abstract available

CANNATELLI R, Bazarova A, Zardo D, Nardone OM, et al
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
Inflamm Bowel Dis. 2021;27:647-654.
PubMed Abstract available

GOREN G, Schwartz D, Friger M, Banai H, et al
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
PubMed Abstract available

ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
PubMed Abstract available

SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
PubMed Abstract available

March 2021

HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
PubMed Abstract available

FANG J, Wang H, Xue Z, Cheng Y, et al
PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
PubMed Abstract available

SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
PubMed Abstract available

KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
Trajectories of Fatigue in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
PubMed Abstract available

STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
PubMed Abstract available

ZHANG T, Xu Y, Yao Y, Jin L, et al
Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
PubMed Abstract available

SANDS BE, Long MD, Reinisch W, Panes J, et al
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
PubMed Abstract available

GARRIDO I, Lopes S, Macedo G
Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
PubMed Abstract available

KHORSHID M, AbdAllah M
Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
Inflamm Bowel Dis. 2021;27:e39.
PubMed

WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:590-592.
PubMed

AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
Inflamm Bowel Dis. 2021;27:585-589.
PubMed

SANTANA GO, de Santana AC, Pfeilsticker VB
Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
Inflamm Bowel Dis. 2021;27:e42.
PubMed

SEDANO R, Dhaliwal I, Ramsewak D, Jairath V, et al
Drug-induced Lupus Associated With Vedolizumab in a Patient with Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e47-e48.
PubMed

FERNANDEZ ALVAREZ P, Maldonado Perez B, Castro Laria L, Arguelles-Arias F, et al
Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e40-e41.
PubMed

ZHOU G, Wu H, Lin J, Lin R, et al
TRIM21 Is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.
Inflamm Bowel Dis. 2021;27:458-468.
PubMed Abstract available

DALAL RS, Palchaudhuri S, Snider CK, Lewis JD, et al
Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:500-506.
PubMed Abstract available

COLMAN RJ, Portocarrero-Castillo A, Chona D, Hellmann J, et al
Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.
Inflamm Bowel Dis. 2021;27:507-515.
PubMed Abstract available

PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
PubMed Abstract available

BHAT S, Caldera F, Farraye FA
Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
PubMed

ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
PubMed Abstract available

XIANG BJ, Huang YH, Dai C
A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
PubMed

SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
PubMed Abstract available

ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
PubMed Abstract available

TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
PubMed

February 2021

VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
PubMed Abstract available

NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
PubMed

IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
PubMed

BORGHINI R, Vescovo M, Giordano C, Donato G, et al
Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
PubMed

MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
PubMed Abstract available

CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
PubMed Abstract available

MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
PubMed Abstract available

CHUGH R, Proctor DD, Little A, Myung P, et al
Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
Inflamm Bowel Dis. 2021;27:e30-e31.
PubMed

SOFFER S, Dahan S, Maklakovski M, Dagan A, et al
A Case of Aseptic Renal Abscesses Associated With IBD.
Inflamm Bowel Dis. 2021;27:e28-e29.
PubMed

LEON G, Hussey S, Walsh PT
The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution.
Inflamm Bowel Dis. 2021;27:440-450.
PubMed Abstract available

YANG Y, Zhang C, Jing D, He H, et al
IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:407-417.
PubMed Abstract available

STEINER CA, Rodansky ES, Johnson LA, Berinstein JA, et al
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
Inflamm Bowel Dis. 2021;27:303-316.
PubMed Abstract available

SCHARRER S, Lissner D, Primas C, Reinisch W, et al
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2021;27:379-385.
PubMed Abstract available

BRENNER EJ, Long MD, Mann CM, Chen W, et al
Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.
Inflamm Bowel Dis. 2021;27:344-351.
PubMed Abstract available

STONE JK, Shafer LA, Graff LA, Lix L, et al
Utility of the MARS-5 in Assessing Medication Adherence in IBD.
Inflamm Bowel Dis. 2021;27:317-324.
PubMed Abstract available

TAXONERA C, Olivares D, Alba C
Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
PubMed Abstract available

PANES J, Lindsay JO, Teich N, Lindgren S, et al
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
PubMed Abstract available

DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
PubMed Abstract available

DALAL RS, Allegretti JR
Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
PubMed

JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
PubMed

MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
PubMed Abstract available

BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
PubMed Abstract available

DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
PubMed Abstract available

BALDAN-MARTIN M, Chaparro M, Gisbert JP
Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
PubMed Abstract available

GARG R, Mohammed A, Singh A, Regueiro M, et al
Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
PubMed Abstract available

January 2021

RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
PubMed Abstract available

ROBERTSON AR, Arnott ID
How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
PubMed

Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
PubMed

SHAH J, Shah A, Hassman L, Gutierrez A, et al
Ocular Manifestations of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
PubMed Abstract available

CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
PubMed

DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
PubMed

SORRENTINO D, Gray JM
Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
PubMed Abstract available

SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
PubMed Abstract available

SEDANO R, Jairath V
Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
PubMed

SEDANO R, Jairath V
High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
PubMed

BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:155-161.
PubMed Abstract available

HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
Inflamm Bowel Dis. 2021;27:291-294.
PubMed

LEE S, Clark-Snustad K
Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.
Inflamm Bowel Dis. 2021;27:e20-e22.
PubMed

DOS SANTOS CHM, Galindo ACA, da Silva BA, Dantas CR, et al
Is There Really a Direct Relationship Between IBD and Anxiety/Depression, or Could Any Chronic Disease Have These Manifestations?
Inflamm Bowel Dis. 2021;27:e18-e19.
PubMed

NIGHOT P, Ma T
Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.
Inflamm Bowel Dis. 2021;27:283-290.
PubMed Abstract available

VAGIANOS K, Shafer LA, Witges K, Targownik LE, et al
Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.
Inflamm Bowel Dis. 2021;27:190-202.
PubMed Abstract available

SCHNELL A, Schwarz B, Wahlbuhl M, Allabauer I, et al
Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy.
Inflamm Bowel Dis. 2021;27:224-235.
PubMed Abstract available

DE CARVALHO LGF, Lima WG, Coelho LGV, Cardoso VN, et al
Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2021;27:169-181.
PubMed Abstract available

MACALUSO FS, Fries W, Viola A, Centritto A, et al
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.
Inflamm Bowel Dis. 2021;27:182-189.
PubMed Abstract available

BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
PubMed Abstract available

DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
PubMed

TA AD, Ollberding NJ, Karns R, Haberman Y, et al
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
PubMed Abstract available

ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
PubMed

CHANDE N, Singh S, Narula N, Gordon M, et al
Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
PubMed

WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
PubMed Abstract available

LI N, Zhan S, Tian Z, Liu C, et al
Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
PubMed Abstract available

REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
PubMed Abstract available

FOULON A, Pichois R, Sabbagh C, Fumery M, et al
Bowel Endometriosis Mimicking Crohn Disease.
Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
PubMed

PUGLIESE D, Schepis T, Bove V, Privitera G, et al
Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
PubMed

KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
PubMed Abstract available

HONG S, Zaki TA, Main M, Hine AM, et al
Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
PubMed Abstract available

SCHARRER S, Primas C, Eichinger S, Tonko S, et al
Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
PubMed Abstract available

BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
PubMed

JEON Y, Limketkai BN
Implications of Dietary Impact on Hepatic Steatosis and IBD.
Inflamm Bowel Dis. 2021;27:10-11.
PubMed

PENRICE DD, Kamboj AK, Simonetto DA
Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
Inflamm Bowel Dis. 2021;27:e7-e8.
PubMed

REINISCH W, Gecse K, Halfvarson J, Irving PM, et al
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
Inflamm Bowel Dis. 2021;27:106-122.
PubMed Abstract available

RIPOLLES T, Poza J, Suarez Ferrer C, Martinez-Perez MJ, et al
Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study.
Inflamm Bowel Dis. 2021;27:145-154.
PubMed Abstract available

OLAISEN M, Flatberg A, Granlund AVB, Royset ES, et al
Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
Inflamm Bowel Dis. 2021;27:12-24.
PubMed Abstract available

CHICCO F, Magri S, Cingolani A, Paduano D, et al
Multidimensional Impact of Mediterranean Diet on IBD Patients.
Inflamm Bowel Dis. 2021;27:1-9.
PubMed Abstract available

CALDERA F, Ley D, Hayney MS, Farraye FA, et al
Optimizing Immunization Strategies in Patients with IBD.
Inflamm Bowel Dis. 2021;27:123-133.
PubMed Abstract available

ARVANITIS M, Hart LC, DeWalt DA, Diaz-Gonzalez de Ferris ME, et al
Transition Readiness Not Associated With Measures of Health in Youth With IBD.
Inflamm Bowel Dis. 2021;27:49-57.
PubMed Abstract available

SZIGETHY E, Murphy SM, Ehrlich OG, Engel-Nitz NM, et al
Mental Health Costs of Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021;27:40-48.
PubMed Abstract available

SEGAL JP, Askari A, Clark SK, Hart AL, et al
The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
Inflamm Bowel Dis. 2021;27:34-39.
PubMed Abstract available

VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort.
Inflamm Bowel Dis. 2021;27:65-73.
PubMed Abstract available

December 2020

HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
PubMed Abstract available

HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
PubMed

BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
PubMed Abstract available

QIN X
More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
PubMed

CURTIS JR, Regueiro M, Yun H, Su C, et al
Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
PubMed Abstract available

DWADASI S, Zafer M, Goens D, Paknikar R, et al
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
PubMed Abstract available

PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
PubMed Abstract available

MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
PubMed Abstract available

LEE C, Hong SN, Kim ER, Chang DK, et al
Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
PubMed Abstract available

BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
PubMed Abstract available

LEE SH, Walshe M, Oh EH, Hwang SW, et al
Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
PubMed Abstract available

November 2020

BATTAT R, Lukin D, Scherl EJ, Pola S, et al
Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
PubMed Abstract available

BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
PubMed Abstract available

YOON H, Jangi S, Dulai PS, Boland BS, et al
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
PubMed Abstract available

DIMOPOULOS C, Al-Bawardy B
SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
Inflamm Bowel Dis. 2020;26:e153-e154.
PubMed

UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
PubMed Abstract available

BROMS G, Friedman S, Kim SC, Wood ME, et al
The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
PubMed Abstract available

GEEM D, Kugathasan S
It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
PubMed

SEDANO R, Jairath V
Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
PubMed

ATTAUABI M, Burisch J, Seidelin JB
Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
PubMed

GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
PubMed Abstract available

BRETON J, Witmer CM, Zhang Y, Downing M, et al
Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
PubMed Abstract available

SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
PubMed Abstract available

RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
PubMed Abstract available

SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
PubMed Abstract available

CORDES F, Lenker E, Weinhage T, Spille LJ, et al
Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
PubMed Abstract available

SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
PubMed

HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
PubMed Abstract available

ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
PubMed Abstract available

BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
PubMed Abstract available

BLOOMFELD RS, Bickston SJ
Financial Toxicity in People With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
PubMed Abstract available

October 2020

DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
PubMed Abstract available

RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
PubMed Abstract available

BEHZAD C, Taheri H, Kashifard M
Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
Inflamm Bowel Dis. 2020;26:e140.
PubMed

HORRIGAN JM, Siegel CA, Tadros M
Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
Inflamm Bowel Dis. 2020;26:e137.
PubMed

ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
Inflamm Bowel Dis. 2020;26:1771-1778.
PubMed

MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
PubMed Abstract available

FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
PubMed Abstract available

RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
PubMed Abstract available

KE J, He R, Hou X
Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
PubMed

ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
PubMed Abstract available

VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
PubMed Abstract available

DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
PubMed

CHEN G, Lissoos T, Dieyi C, Null KD, et al
Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
PubMed Abstract available

DOS SANTOS CHM, Koga GA
The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
PubMed

TRINDADE IA, Ferreira NB
COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
PubMed Abstract available

MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
PubMed

FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
PubMed

FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
PubMed Abstract available

September 2020

YU Q
Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
PubMed Abstract available

PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
PubMed Abstract available

KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
PubMed Abstract available

SINH P, Cross R
Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
PubMed Abstract available

NAVANEETHAN U, LehnerNoguera V
Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
Inflamm Bowel Dis. 2020;26:e124.
PubMed

August 2020

ZHANG Q, Chen D, Yang Y
Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
Inflamm Bowel Dis. 2020;26:e101.
PubMed

July 2020

GOYAL A
Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
Inflamm Bowel Dis. 2020;26:1222-1224.
PubMed

June 2020

FLESHNER P
Editorial on Hirten et al.
Inflamm Bowel Dis. 2020;26:1059.
PubMed

LIGHTNER AL
Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
Inflamm Bowel Dis. 2020;26:1087-1088.
PubMed

May 2020

XU F, Chen D, Yang Y
Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
Inflamm Bowel Dis. 2020;26:e47.
PubMed

MCHENRY S, Ciorba MA, Deepak P
Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2020;26:e46.
PubMed

DAVIS BC
Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
Inflamm Bowel Dis. 2020;26:960.
PubMed

ZUNDLER S
Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
Inflamm Bowel Dis. 2020;26:907-908.
PubMed Abstract available

LUKIN DJ
Predictors of Perianal Fistula Relapse in Crohn's Disease.
Inflamm Bowel Dis. 2020;26:932-933.
PubMed

April 2020

KOUTROUMPAKIS F, Lodhi M, Ahsan M, Ramos Rivers C, et al
The Impact of Cholecystectomy on Long-Term Disease Outcomes and Quality of Life in Patients with Crohn's Disease.
Inflamm Bowel Dis. 2020 Apr 20. pii: 5822893. doi: 10.1093.
PubMed Abstract available

TURNER D
Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
Inflamm Bowel Dis. 2020;26:e42.
PubMed

LIN S, Lin X, Li X, Chen M, et al
Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
Inflamm Bowel Dis. 2020;26:743-745.
PubMed

March 2020

LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
Inflamm Bowel Dis. 2020;26:510-514.
PubMed Abstract available

BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
Inflamm Bowel Dis. 2020;26:628-634.
PubMed Abstract available

February 2020

GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
Inflamm Bowel Dis. 2020;26:e17-e18.
PubMed

JUKEMA JB, Brandse JF, de Boer NKH
Successful Treatment of Oral Crohn's Disease by Ustekinumab.
Inflamm Bowel Dis. 2020;26:e19.
PubMed

SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
Inflamm Bowel Dis. 2020;26:407-422.
PubMed Abstract available

JUN X, Ning C, Yang S, Zhe W, et al
Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
Inflamm Bowel Dis. 2020;26:380-390.
PubMed Abstract available

CORDES F, Lenker E, Spille LJ, Weinhage T, et al
Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
Inflamm Bowel Dis. 2020;26:391-406.
PubMed Abstract available

VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
Inflamm Bowel Dis. 2020;26:369-379.
PubMed Abstract available

GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
Inflamm Bowel Dis. 2020;26:423-428.
PubMed Abstract available

January 2020

KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
Inflamm Bowel Dis. 2020;26:216-228.
PubMed Abstract available

WANG X, Bootsma H, Kroese F, Dijkstra G, et al
Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
Inflamm Bowel Dis. 2020;26:e8-e9.
PubMed

LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
Inflamm Bowel Dis. 2020;26:304-313.
PubMed Abstract available

EGBERG MD, Galanko JA, Kappelman MD
Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
Inflamm Bowel Dis. 2020;26:254-260.
PubMed Abstract available

LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
Inflamm Bowel Dis. 2020;26:321-330.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.